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ABSTRACT 
 
Examining the Effects of Deer Antler Velvet On Muscular Strength, 
Performance, and Markers of Delayed Onset Muscle Soreness 
by 
Robyn Percival 
 
Purpose: To examine the effects of deer antler velvet on muscular strength, performance, and 
markers of delayed onset muscle soreness following a 10-week resistance training period.   
 
Participants: 16 resistance-trained males (18-35) volunteered.  
 
Measures: DEXA, 1-RM, a power test, and a 70% performance trial were measured. Creatine 
kinase and self-reported soreness levels were measured following an eccentric trial 
 
Results: No pre-experimental significant differences existed between the groups for any of the 
variables measured. There were no significant differences between the groups regarding body 
composition, strength, muscular performance, or improvements in creatine kinase and soreness 
levels from pre to post-intervention. Both groups demonstrated significant (p<0.05) increases in 
creatine kinase and soreness levels immediately post-exercise and 48 hours following the 
eccentric trial at the 0 and 10-week measurement periods.  
 
Conclusions: Deer antler velvet does not improve muscle size, strength, or performance. Nor 
does it reduce markers of DOMS following a 10-week supplementation period.  
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CHAPTER 1 
INTRODUCTION 
 
With the introduction of ergogenic aids into athletics, sport at many different levels, 
ranging from recreational to elite, is quickly becoming a science.  Many ergogenic aids are 
proposed to enhance physical, mental, and mechanical properties within athletics. More 
specifically, ergogenic aids have gained enormous popularity by promising to increase a person’s 
over-all strength, muscle development, and maintenance of resistance training gains.  There are 
many factors involved in the development, and maintenance of muscle size.  McKardle, Katch, 
and Katch (1) outline six main factors that are vital in impacting the development of muscle 
mass.  These factors include: genetics, nervous system activation, environmental factors, 
endocrine influences, nutritional status, physical activity, and exercise.   
For optimal muscle growth, it is essential to remember that balancing each modifiable 
factor is important.  For example the hormonal influences on muscle growth require a balance 
between anabolic and catabolic properties of the various hormonal systems (ie., growth-hormone 
versus cortical-steroid factors).  An excess of cortisol will lead to protein breakdown, tissue 
wasting and ultimately cause negative nitrogen balance (1). Exercise can have both positive and 
detrimental effects on muscle development. Specifically, animal studies have shown that 
resistance training can promote both hypertrophy and hyperplasia within the muscle (2, 3). 
Detrimental effects on muscle development can occur as a result of overtraining. Fry and 
Kraemer (4) define overtraining as an increase in volume and or intensity of exercise training 
resulting in long-term performance decrements.  Most overtraining research involves endurance 
based type activities (i.e., marathon training).  However, other exercises such as intense weight 
training produce similar overtraining effects, yet few studies exist in this area (4). A possible 
solution for combating the effects of overtraining is the use of ergogenic aid based 
supplementation during training (e.g., protein supplementation, androstenedione, carbohydrate 
supplementation).  It has been proposed that a new supplement, deer antler velvet, may have the 
potential to enhance recovery time following intense physical activity (5).  In addition, the 
substance has been shown to increase muscle strength and size (6). However, there has been little 
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scientific research conducted to support this proposal.  Therefore, it is necessary to examine the 
validity of this proposal under well-controlled laboratory conditions.   
 
Statement of the Problem 
This study used a double blind administration protocol to determine what the effects of 
10 weeks of oral deer antler velvet supplementation had on maximal strength, muscular 
performance, muscular performance recovery, and markers of delayed onset of muscle soreness 
(DOMS) in resistance trained men 18 to 35 years old with at least 4 years experience.  
 
Hypotheses and Testing Objectives 
Hypothesis 1: It was hypothesized that deer antler velvet would significantly enhance 
maximal muscle strength after 10 weeks of oral supplementation in resistance trained men 
compared to a resistance trained placebo group.  
Testing Objective For Hypothesis 1: Maximal muscle strength was evaluated by 
determining the maximal amount of weight that could be lifted one time (1-RM) for the bench 
press and squat exercise movements before and after 10 weeks with and without the use of oral 
deer antler velvet supplementation.  
Hypothesis 2: It was hypothesized that deer antler velvet would significantly enhance 
muscular performance after 10 weeks of oral supplementation in resistance trained men 
compared to a resistance trained placebo group. 
Testing Objective For Hypothesis 2: Muscular performance was assessed by comparing 
each subject’s ability to lift 70% of his 1-RM values for the bench press and squat lifting results 
before and after 10 weeks with and without oral deer antler velvet supplementation. In addition, 
not only were the number of repetitions determined but the amount of seconds to complete them. 
Thus, muscular performance was also assessed based on the number reps/sec. 
Hypothesis 3: It was hypothesized that 10 weeks of oral deer antler velvet supplementation 
would significantly enhance muscular performance recovery after completing an eccentric 
exercise trial to induce DOMS in a resistance trained men. 
Testing Objective For Hypothesis 3: Muscular performance recovery was assessed by 
determining how many times each person lifted 70% of his 1-RM values for the bench and squat 
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exercises 48-hrs after completing an eccentric exercise trial to induce DOMS with and without 
oral deer antler velvet supplementation.  
Hypothesis 4: It was hypothesized that 10 weeks of oral deer antler velvet supplementation 
will significantly reduce the markers of DOMS including ratings of muscular pain and creatine 
kinase.  
Testing Objective For Hypothesis 4: The pain markers of DOMS were assessed by using a 
standardized procedure for rating muscle soreness of primary muscle groups involved in the 
bench press and squat prior to, immediately following, and 48-hrs after the eccentric exercise 
trial. In addition, blood samples were taken at the same time periods to determine each person’s 
creatine kinase levels (a marker of muscle damage). 
 
Delimitations 
Each subject met the specific requirements in order to be eligible for the study, These 
requirements were as follows: The participants were males between the ages of 18 and 35. A 
minimum of 4 years of weight lifting experience was necessary to participate in the study. Each 
subject avoided additional supplementation such as prohormones or anabolic steroids prior to or 
during the 10-week study.  Each subject maintained regular dietary habits and avoided additional 
training that was outside the scope of the specific training protocol provided.  Height, weight, 
and body composition were obtained for each subject before and after the 10-week training 
period. In addition, a pre/post measure of one repetition maximum, anaerobic power, and aerobic 
capacity were obtained following the 10-week period. A pre-training blood profile was obtained 
to establish a resting baseline for cholesterol profiles, blood glucose levels, and markers of liver 
and kidney function.  Blood samples were collected pre, post and 48 hours, following an acute 
training bout specifically designed to investigate muscular power and the effects of  DOMS. 
Similar blood samples were also obtained at the end of the 10-week training program. 
 
Assumptions 
1. Each subject avoided any supplements other than deer antler velvet or placebo during the 10- 
week time frame of the study. 
2. Subjects were truthful concerning the guidelines required to be eligible for the study. 
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3. Subjects were truthful about obeying the specified guidelines provided upon initiation of the 
study. 
4. Subjects were truthful when documenting training exercises throughout the investigation. 
5. Subjects did not drastically alter their regular dietary habits throughout the duration of the 
study. 
6. Subjects ingested either the supplement or placebo during the study as described by 
researchers. 
7. Subjects gave a maximal effort during each resistance training period. 
 
Limitations 
1. The subjects were not provided with a specific workout regiments or dietary program. 
However, they were instructed to avoid any drastic changes to either protocols throughout 
the duration of the study. 
2. This investigation used only male subjects, causing the findings to be inapplicable to 
females. 
3. The subjects were males aged 18 to 35, thus the findings cannot be applied to an older 
population. 
4. The results of this study cannot determine the long-term consequences on performance or 
potential chronic use side-effects from the sue of the deer antler velvet supplement. 
 
Definition of Terms 
Delayed onset muscle soreness (DOMS): Muscle soreness that develops a day or two after a 
heavy bout of exercise (7). 
Eccentric Action-Muscle lengthening (7). 
Ergogenic Aid: A substance that can improve athletic performance (7). 
Myosin: One of the proteins that forms filaments that produce muscle action (7). 
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Creatine Kinase: A dimeric protein, often found in muscle following intense eccentric exercise 
(8).  
One Repetition Maximum: The greatest amount of weight that can be lifted through the full 
range of motion only once for a particular lift (7). 
Actin: A thin protein filament that acts with myosin filaments to produce muscle action (7). 
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Introduction 
 Many athletes ranging from a recreational to an elite level strive to improve performance.  
Ergogenic aids have had both a positive and negative impact with regards to competition.  When 
viewed in a positive light, ergogenic aids are able to contribute by elevating sport to a new level.  
However, the negative factors associated with ergogenic aids are the abuse of banned substances 
such as anabolic steroids in an attempt to achieve an unfair competitive edge.  Ergogenic aids are 
often classified in several ways.  These include nutritional, mechanical, physiological, chemical, 
and psychological (9). Examples of these various types of ergogenic aids are presented in Table 
1. 
Table 1. Ergogenic Aids  
Ergogenic Aid Category Specific Examples of Ergogenic Aids 
Chemical Anabolic steroids, growth hormone 
Mechanical Aero handle bars, specialized clothing 
Nutritional Carbohydrate, protein supplementation 
Physiological Blood doping 
Psychological Visualization 
 
It is apparent that many ergogenic aids are in existence today and that new ones are continually 
being developed and marketed to athletes.  One such example of a new supplement is the 
introduction of deer antler velvet into the western world.  Traditionally, deer antler velvet has 
been used in eastern medicine as a powerful healing remedy; however, new hypotheses exist 
concerning the possibility of it being used as a performance enhancement supplement.  It is 
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believed to increase strength and growth of the muscles in addition to acting as an anti-
inflammatory agent (10, 11).  
 
Deer Antler Velvet 
 According to Wang (11) deer antler velvet has been used in Chinese medicine for over 
2000 years.  Velvet Antler comes from deer and is produced during the regeneration and growth 
stage that occurs each spring.  A medicinal form of deer antler velvet that contains all its active 
ingredients is a substance called Pantocrine. According to Pavlenko (12), pantocrine is made 
from the young unossified horns of spotty deer and maral.  Velvet Antler is not classified as 
bone, it begins as protein collagen which eventually matures into cartilage and then bone. This 
process is influenced by the stag’s sex hormones (6). The velvet is removed from the antler and 
processed during the optimum regeneration period. This occurs health with no harm to the 
animal. 
Velvet is composed primarily of 34% ash, 12% moisture, and 54% organic substances 
(contributed to by 10% total nitrogen and 3% fat) (6).   Pantocrine is the fatty portion that is 
extracted from the velvet in the antler.  Approximately 86% of the fat located in the velvet is 
extracted to make pantocrine (6). The mineral content that appears in pantocrine is aluminum, 
calcium, iron, magnesium, potassium, phosphorus, silicon, and sodium.  In addition, there are 
many amino acids found in pantocrine.  These include glycine, alanine, and proline. It is believed 
that these contribute to influencing the processes of growth, metabolism, and biosynthesis in 
living organisms (6).  
Although deer antler velvet is mainly used in Chinese medicine to promote wellness and 
prevent illness, it is believed to have many health benefits.  Suggested benefits of deer antler 
velvet include: possible growth effects, improved immune function, anti-inflammatory and anti-
cancer properties, reductions in anemia, increased athletic performance, decreased recovery time 
following surgery, memory enhancement, improved blood pressure and cardiovascular function, 
anti-aging and gonadotrophin effects, and reductions in cholesterol (10, 11, 13-15). Although, 
velvet antler is believed to benefit all of these ailments, physicians are skeptical about its many 
curative properties.  They find it impossible that one type of medicine can affect so many 
different diseases that are of no relation to each other (12).    
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 Velvet Antler is believed to have a positive impact on growth and neuromuscular 
function, which could ultimately affect muscle strength and size. A New Zealand in-house report 
(1982) outlines several studies with respect to growth.  For example, Mineshita, indicates that 
administering velvet antler to tadpoles may accelerate the growth process. Whereas feeding 
velvet antler to mice may not benefit growth processes. Bae (10) demonstrated that feeding the 
substance to chicks increased body weight and feeding efficiency.  However, Jiang (6) reported 
that velvet antler does not stimulate growth in frogs. Thus, these results suggest that there is an 
additional need for further research in this area.  
 The report (6) outlined neuromuscular function as follows: Kiselev and Pavlovskaya (6) 
showed that pantocrine was able to increase the contractions in fatigued frogs by apparently 
shortening the synaptic delay in the neuromuscular junction. Also simple and complex reflexes 
were accelerated (27% and 34.5% respectively) in hypoxic frogs following the administration of 
pantocrine.  
Interestingly, the report indicates that the low toxicity level of the velvet antler during 
preparation testifies the substance being harmless when administrated.  Following administration 
of velvet antler, there were no reported side effects with regards to the internal organs. There 
were no differences in the comparative weight of the organs such as the spleen, thymus, liver, 
heart, kidneys, ovaries, and adrenals. Also, no effects on blood proteins were observed.   
 Although there appears to be a lot of literature on deer antler velvet, New Zealand reports 
difficulty when trying to compile various sources.  Much of the information originates from 
Russia, Japan, China, and Korea. Some problems encountered were that some of the journals 
were unattainable, many of the articles did not contain abstracts, often the standards are different 
when conducting research making it difficult to compare testing, and finally few articles were set 
in English.  
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As mentioned previously, a response to DOMS is an inflammatory reaction. It is 
hypothesized that supplementation of deer antler velvet is shown to have anti-inflammatory 
effects. In addition, it is believed that pantocrine may contribute to acceleration of the 
regenerative processes of injured tissue (12). During World War II pantocrine was administered 
to soldiers who were suffering from various wounds and ulcers. Yudin and Dobryakov have 
indicated that deer antler velvet or pantocrine (an extract of deer antler velvet) has induced anti-
inflammatory activity.  AgResearch tested New Zealand velvet antler to examine the anti-
inflammatory effects.  They induced inflammation in mice by administering thioglycollate, 
which causes neutrophils to be released approximately 18-24 hours following injection.  Mice 
were placed into three groups, a deer antler velvet group, a thioglycollate group, and a control 
group.  Then, the mice were killed in order to examine the white blood cell activity.  The results 
indicated that deer antler velvet group suppressed neutrophil production when compared to the 
other two groups.  However, the actual mechanism that causes the suppression of neutrophil 
production is unknown.  It is believed by Wang (11), that the antler produces cytokines, which 
ultimately aids in reducing the inflammatory response.  
As mentioned previously, the mechanisms behind DOMS are similar to inflammatory 
response.  Deer antler velvet could reduce DOMS by possibly suppressing neutrophil production 
or increasing cytokines (11, 16). Also, the growth properties associated with velvet antler could 
allow muscle to increase in fiber size and number (10). Thus, making the tissue more resilient to 
any damage that might occur with overtraining type exercise. If muscle tissue is stronger, then 
the likelihood that DOMS could occur is dramatically reduced.  These properties may contribute 
to ultimately decreasing recovery time. 
In order to gain a better understanding of how deer antler velvet acts as an ergogenic aid 
and its role in reducing DOMS, the following pertinent areas will be reviewed, muscle 
physiology, delayed onset muscle soreness, and creatine kinase as a marker of DOMS. 
 
Muscle Physiology 
 Muscle is composed of fibers that are held together by connective tissue.  The connective 
tissue, which serves to protect muscle fibers, consists of the endomysium, perimysium, 
fasciculus, and epimysium (1).  Each individual muscle fiber consists of myofibrils, which are 
composed of numerous sarcomeres. There are 12 different proteins located within the myofibril; 
however, actin and myosin account for approximately 85% of the structure.   Actin, along with 
troponin and tropomyosin, make up the thin filament of the sarcomere, while myosin composes 
the thick filament.  In addition, each sarcomere complex is connected by Z-disks. Between Z-
disks, are the I-band, A band, H zone, and M line which are light and dark in nature and 
contribute to the muscles striated appearance. (1).   
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 Both mechanical and chemical changes must occur in order for a muscle to contract.  
Wilmore and Costill (7) outline a sequence of events that occurs during muscle contraction. 
Initially, the motor unit, which is comprised of a single motor nerve and all the muscle fibers, 
must be stimulated in order to cause a muscle related action potential.  Stimulation occurs via a 
motor nerve impulse which then induces the release of the neurotransmitter, acetylcholine.  
When enough acetylcholine crosses the neuromuscular junction, successfully and binds to 
receptors on the sarcolemma, an electrical charge is generated which is known as an action 
potential.  The action potential travels across the membrane until it reaches the sarcoplasmic 
reticulum, which causes the stored calcium to be released.  The calcium binds to troponin, which 
as mentioned previously is located on the thin filament. The binding effect causes tropomyosin 
to lift off the actin filaments in order to allow myosin heads to attach to the actin filament (7).  
The process in which actin and myosin attach is known as the sliding filament theory, which was 
first established by H.E. Huxley and A.F. Huxley in 1954 (17). It is believed that the muscle 
undergoes a cross-bridge cycle, which is fueled by the hydrolization of adenosine triphospate 
(ATP) to adenosine diphosphate (ADP). The components of the cross-bridge cycle include the 
initial release of calcium, which stimulates the binding of myosin heads to actin.  Myosin heads 
have stored ATP, which provides the fuel that allows actin and myosin to move past each other.  
The filaments do not actually shorten, they slide past each other which causes the H zone to 
become smaller and induces eventual shortening of each sarcomere.  Free energy is created as a 
result of the hydrolysis process and binds to myosin in order to prepare for the next contraction.   
 As mentioned previously, muscle is made up of many fibers that are held together via 
connective tissue.  There are different classifications of muscle fibers that are recruited in order 
to perform specialized functions.  The two main types are fast twitch muscle fibers, also known 
as type II and slow twitch muscle fibers, also known as type I.  Fast twitch fibers are required for 
quick explosive type actions that primarily depend on the short-term glycolytic system for 
energy. These fibers are also 3 to 5 times faster with regards to contracting and shortening when 
compared to slow twitch muscle fibers (1).  In contrast, slow twitch muscle fibers are recruited 
during prolonged lower intensity exercise.   These fibers contain numerous mitochondria and 
have a very high capillary to fiber density which allow the muscle to sustain extended aerobic 
exercise.  The slow contraction period involving shortening and lengthening of the sarcomere 
allows this fiber type to be fatigue resistant (1).   
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The primary muscle fiber type that is used in resistance training is fast-twitch muscle 
fiber.  Repeated contraction occurring in the muscle, specifically fast twitch fibers, can lead to 
hypertrophy of the muscle tissue.  Hypertrophy has been observed in both animal and human 
studies employing various resistance training protocols. McCall, Byrnes, Dickinson, Pattany and 
Fleck (2)examined the effects of a resistance training program on muscle hypertrophy (increase 
in muscle size) and hyperplasia (increase in fiber number) in 12 college age males.  Magnetic 
resonance imaging and muscle biopsies were obtained in order to determine the effects of the 
training protocol on muscle tissue.  The results indicated that there was a significant increase in 
strength from week 3 to week 9 at the p<0.05 level. There were significant increases (p< 0.05) in 
cross-sectional muscle area in the biceps brachii (12.6%), triceps brachii (25.1%), and total arm 
(14.6%) as a result of training. Fiber size for both type I (10%) and type II (17.1%) muscle fibers 
significantly increased at the p<0.05 level.  However, there was no significant increase in the 
number of muscle fibers. The estimated number of fibers during the pretraining period was 293.2 
± 61.5 Χ 103 whereas after the post-training period the estimated number of fibers was 297.5 ± 
69.5 X 103.   Thus establishing that muscle hypertrophy occurs as a result of resistance training 
whereas muscle hyperplasia does not.  In contrast, Tamaki et al., (3) found that hyperplasia 
occurred in response to weight lifting in untrained rats.  The researchers trained male Wistar rats 
using resistance exercises designed to use hind limb muscles. In order to measure development 
of new tissue, 5-bromo-2′-deoxyuridine (BrdU) was injected into the tissue before sampling.  
BrdU is a marker that is used to measure DNA synthesis and is often used when examining 
proliferation of the muscle tissue.  The results indicated a significant increase in anti-BrdU 
positive cells 1.5 to 2 days after exercise, which is displayed in Figure 1. 
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Figure 1. Serial Changes in Number of Anti-BrdU-Positive Cells in Histological Sections From 
Plantaris Muscle.  Note the significant increase in the number of BrdU-positive cells 1-3 days 
after exercise.  Note also that the peak number of anti-BrdU-positive cells is seen 36-48 h after 
exercise.  Values are mean counts ±SE per section.  **P<0.01 compared with resting values 
 
In addition to the increase in anti-BrdU cells, there was a presence of satellite cells (119 ± 
33/section) which are precursors to muscle regeneration.  This study suggests that following 
resistance training, damage occurs in the muscle tissue, which then activates satellite cells and 
could contribute to possible regeneration of damaged muscle tissue.  Also, there was evidence of 
new fibers present in the interstitial space of the muscle, which was reported via electron 
microscopy.  These findings indicate that muscle may undergo both hypertrophy and hyperplasia 
following resistance training exercise.  However, some authorities believe that hypertrophy is the 
main effect in human muscle growth following resistance training (1). Resistance training has 
been shown to be beneficial for contributing to overall increases in muscle size and strength.  
However, when resistance training causes decreases in performance the result is overtraining. 
Overtraining, as defined by Fry and Kraemer (4) is the overall increase in volume or intensity, 
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which results in long term performance decrements.  Fry and Kraemer state that overtraining is 
best described as a continuum of events, which is outlined in Figure 2. 
  
Overreaching 
(positive 
adaptation if sued 
correctly) 
Overtraining 
(maladaptation, 
decreased 
performance) 
Acute fatigue 
(positive 
adaptation to 
training) 
Acute 
Exercise 
Stimulus 
Figure 2. Overtraining Continuum from Fry and Kraemer to Show the Progression of Overtraining. 
Overtraining may result in a variety endocrine responses that may affect performance.  
Fry and Kraemer (4) review that resting testosterone levels have been shown to both increase and 
decrease following overtraining.  Also cortisol levels have been shown to increase and decrease.  
Suggestions for an increase in resting cortisol could be due to the need to replenish energy stores.  
The decrease in cortisol could be due to down regulation of production as a result of existing 
high levels in the blood.  No change in growth hormone has been reported due to overtraining. 
Although Fry and Kraemer (4) have defined overtraining, not all studies adopt the same criteria.  
This makes it difficult to find definitive results with respect to how overtraining impacts 
performance.  Further research needs to be done and a clear definition needs to be developed in 
order to understand all of the implications associated with overtraining. 
 
DOMS 
An acute form of overtraining that can occur following resistance training is delayed 
onset muscle soreness.  It is the most prevalent in untrained individuals following intense 
exercise. DOMS is described as a feeling of discomfort or pain within the muscle following 
unaccustomed muscular exertion. It is common in individuals who initiate an unfamiliar exercise 
regime.  Untrained individuals may experience discomfort, which peaks approximately 24-48 
hours after an intense bout of exercise (18). Although, the soreness associated with DOMS is 
acute in nature and is not debilitating, it can reduce muscular performance. The underlying 
mechanisms that cause DOMS is unknown; however, it is believed that mechanical injury 
followed by biochemical forces damage muscle tissue following intense exercise (18).  
Armstrong (18) proposed that DOMS may follow a distinct sequence of events.  Following 
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exercise, mechanical forces act on the muscle, which causes a disruption of structural proteins in 
muscle fibers and tissue.  This elicits an influx of calcium as a result of the altered permeable 
state in the cell membrane.  High calcium concentrations may inhibit oxidative phosphorylation 
and also activate a proteolytic enzyme that degrades the Z-discs in the muscle.   The eventual 
degradation of the muscle attracts monocytes that convert to macrophages to remove damaged 
tissue.  Finally, Armstrong proposes that the sensation of DOMS is stimulated by the 
accumulation of histamine, kinins, and potassium and an increase in edema which affect group 
IV nerve endings.   
Similar to Armstrong’s proposed sequence of events is Smith’s (19) hypothesis related to 
the etiology of DOMS.  Smith (19) states that initially disruption occurs within connective and/or 
contractile tissue following exercise.  Then the damaged tissue experiences an elevation in 
neutrophils, which eventually migrate from circulation to the site of tissue injury.  This is 
followed by an increase in monocytes approximately 6 to 12 hours after the initial injury.  
Macrophages begin to make prostaglandins (PGE2) which signal the type III and IV pain 
afferents.  Finally, Smith states that the pain is induced by edema which leads to an increase in 
intra-muscular pressure which in turn may stimulate pain receptors upon palpation of the 
effected area. In spite of the similarity that exists between the two proposed pathways, both 
indicate that more research needs to be conducted in order to establish the exact cause of DOMS. 
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As previously mentioned by Smith (19) neutrophils are involved in the initial processes 
of DOMS. Pyne (20) also recognize that neutrophils are recruited as the first line of defense in 
order to combat against injury and inflammation.  He indicates that neutrophils are obtained from 
the bloodstream and attracted to the area of injury, upon arrival they will signal for additional 
neutrophils, immonugloubulins, and cytokines to promote the repair process.  Neutrophils are 
phagocytotic in nature and function by engulfing foreign invaders and bacteria.  Armstrong (18) 
stated that z-disks might become damaged during exercise as a result of proteolytic enzymes 
being released.  Pyne (20) suggests that neutrophils may function by engulfing the damaged 
tissue in the myofibrils following intense exercise.  Although neutrophils function to remove 
foreign material, they are not efficient in distinguishing between healthy tissue and damaged 
tissue.  Thus, they may actually contribute to the local inflammatory response by also invading 
healthy tissue and cytokines that are released to further mediate tissue repair.  Pedersen, 
Ostrwoski, Rhode and Bruunsgaard (21) report that cytokines such as interleukin IL-6, tumor 
necrosis factor-α (TNF) and increase in response to inflammation following eccentric exercise.  
They report that cytokines are released in order to promote the healing process following 
inflammation of muscle tissue.  A review by MacIntyre, Reid and McKenzie (22) also indicated 
that there is an increase in cytokine activity following exercise.  The specific cytokines released 
are interleukin-1, interleukin-6 and tumor necrosis factor. An investigation by Stauber, Fritz, 
Vogelbach and Dahlmann (23) examined the effect of muscle lengthening of the soleus in 18 
male rats on DOMS and related muscle damage.  The results indicated that necrotic tissue was 
present possibly due to tumor necrosis factor. TNF is a cytokine that is produced by neutrophils, 
lymphocytes, macrophages, natural killer cells, lymphokine activated killer cells, astrocytes, 
endothelial cells, and smooth muscle cells.  It is released in response to injury in order to destroy 
and kill injured tissue, ultimately allowing growth and regeneration of new tissue.  Also 
macrophages were present but were not the predominant cell type.   
Monocytes and macrophages are also believed to play a role in the inflammatory process 
associated with DOMS.  They engulf the neutrophils that are located in the damaged necrotic 
tissue and also produce various other cytokines, to promote the healing process (22). 
  Although, the specific etiology has not yet been determined, the conditions under which 
DOMS is the most prevalent have been established.  Evidence indicates that the syndrome 
predominantly occurs following eccentric exercise and is the most prevalent in untrained 
individuals. Stauber et al. (23) observe that at 48 hour post exercise mean perceived soreness 
increased from a rating of 1 to 8 on a scale of 10 being the highest. The scale was defined as 
follows: 1 was classified as normal whereas 10 was defined as being very sore. They also 
observed extracellular matrix damage within the muscle following eccentric exercise.  Evans et 
al. (24) indicate that following a 45-minute bout of eccentric exercise on the cycle ergometer 
untrained men experienced significantly elevated (p<0.01) levels of creatine kinase 3 hours after 
exercise that continued to increase for 5 days reaching a level 33 times greater than base line 
level.  Interleukin-I was also significantly higher (p<0.01) in the untrained men when compared 
to trained men. The metabolic response incurred suggests that following eccentric exercise 
delayed onset muscle soreness is more prevalent in untrained individuals.   
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It has also been suggested that eccentric exercise may contribute to strength decrements as a 
result of DOMS. A review by McIntyre, Reid and McKenzie (22) indicates that Clarkson and 
colleagues proposed that strength loss may be attributed to overstretched sarcomeres, which 
could affect force production (22).  In addition, McIntyre et al. (22) support findings by Faulkner 
and colleagues who state that some sarcomeres may stay the same while others are stretched 
causing damage.  The overstretching hypothesis could be directly related to eccentric exercise 
due to the continual lengthening of the muscle during exercise.      
As mentioned previously DOMS is not debilitating; however, it may cause decreases in 
strength.  Ironically, a way to prevent the syndrome from occurring is to continue exercise. 
Clarkson and Tremblay (25) found that following recovery from DOMS, the muscle tissue was 
able to heal and make adaptations in order to prevent future injury. They investigated the effects 
of exercise induced muscle damage, repair, and adaptation in women.  Eight college-aged 
women performed eccentric exercises using both the right and left forearm.  The exercise 
protocol was as follows: One arm was required to complete 70 maximal contractions (70-Max), 
while the other arm only completed 24 maximal contractions (24-Max), followed by an 
additional 70 maximal contractions (70-Max) 2 weeks later. They measured muscle force, 
soreness, and creatine kinase activity following the 2-week study.  The results indicated that 
there was a significant initial (p<0.01) strength loss and a high rating of perceived soreness 
following the initial 70max contraction protocol.  In addition, there was a significant increase 
(p<0.01) in creatine kinase levels following the initial 70max contraction protocol when 
compared to the 70max2 contraction protocol.  According to these results, it is apparent that the 
muscle undergoes an adaptive phase in order to prevent future exercise damage.  The level of 
creatine kinase and the amount of muscle soreness significantly diminished during the repeated 
bout of exercise when compared to the initial bout.  The muscle became more resistant to 
exercise induced damage and was able to repair the damaged tissue at a faster rate.   
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Vincent and Vincent (26) examined the effect of training status in response to muscle 
soreness following resistance exercise.  Their subjects included 20 college-aged males (mean age 
untrained = 18.2 ± 1.3, trained = 22.7 ± 2.4) who were placed into either a trained group or an 
untrained group.  The trained group was identified as having a minimum of 3 years of 
weightlifting experience whereas the untrained group did not participate in weightlifting for at 
least 3 years.  The training protocol was a split-day leg exercise regime, which targeted the knee 
extensors on day 1 and the knee flexors on day 2.  The results indicated that serum creatine 
kinase was significantly elevated (p<0.01) in the untrained group (CK = 3272 IU) when 
compared to the trained group (CK = 1349 IU).  These results demonstrate that there is an 
adaptive effect that the muscle undergoes in order to prevent further injury and inflammation.  
Vincent et al. (26) state that the sarcolemma may strengthen as a result of chronic exercise 
training thus preventing the leaking out of muscle proteins.  In addition, they hypothesized that 
the permeability of the sarcolemma may have been altered, which could have prevented enzymes 
such as creatine kinase being lost in the bloodstream.  Although it is evident that an adaptation 
occurs with regards to exercise and DOMS, the amount of time for the adaptation to occur is still 
unclear. Nosaka, Clarkson, McGuiggin and Byrne (27) observed the changes in muscle 
adaptation in 2 different groups of college aged females (19.2 ± 0.8 yrs) following eccentric 
exercise.  Group 1 had 6 weeks of recovery time and group 2 had 10 weeks of recovery time 
before repeating the exercise.  Both groups experienced significant decreases (p<0.01) in serum 
creatine kinase activity during the second exercise bout; however, there was no significant 
difference p<0.01) between the groups.  This suggests that time needed for muscle adaptation 
and repair to occur remains unclear.  
 
Acute Performance Following DOMS 
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 A review by McIntyre, Reid, and McKenzie (22) indicates that Clarkson and colleagues 
attribute strength losses to overstretched sarcomeres, which could affect force production (22).  
In addition, McIntyre et al.(22) support findings by Faulkner and colleagues who state that some 
sarcomeres may stay the same while others are stretched, causing damage.  As a result, one 
would expect that performance would decline following an eccentric exercise bout. Several 
studies support the hypothesis that performance declines immediately following heavy eccentric 
exercise when there is damage to the muscle.  A study by Mair and colleagues (28) examined the 
effects of eccentric exercise on 22 male volunteers from a physical education class that ranged in 
age from 20 to 26 years. The volunteers were split into two groups. Group A had exercise 
sessions separated by 4 days and group B had sessions separated by 13 days. The eccentric 
exercise bout involved 7 sets of 10 eccentric contractions of the quadriceps femoris muscle 
group. Performance was tested using the Kistler force platform where the subjects performed 
one-legged vertical jumps, which measured force production and vertical jump height. This test 
was completed before, immediately after, 1, 2, 3, and 4 days following the eccentric exercise for 
both groups. The results indicated that there was a significant (p=0.0001) decline in force 
production following the exercise bout for both groups.  The most pronounced decline was 
observed immediately following; however, performance remained affected up to 4 days after the 
eccentric trial.  A previously mentioned study by Vincent and Vincent (26) demonstrates 
reductions in performance following resistance exercise.  Force during extension and flexion of 
the knee was measured using an isovelocity dynamometer before, immediately after, 1, 2, 3, 4, 5, 
6, and 10 days following the resistance exercise. During the knee extension phase, the baseline 
value for the trained group was 365 ± 83 Nm; the baseline value for the untrained group was 316 
± 34 Nm. Both the trained and untrained group demonstrated a significant (p<0.05) reduction 
(30% and 24% respectively) in isometric peak torque capacity immediately following the 
exercise. During the knee flexion phase, the baseline value for the trained group was 167 ± 11 
Nm; the baseline value for the untrained group was 163 ± 13 Nm.  Again there was a significant 
decrease (p<0.05) in isometric peak torque capacity for both groups (Trained= 25%, Untrained = 
17% following the exercise bout.  Both groups recovered by day 10 of the exercise testing. A 
study by Clarkson and Tremblay (25) also examined the effects of eccentric exercise on force 
production. Eight college aged women performed 3 eccentric trials using a modified arm curl 
machine. Subjects performed 70 maximal contractions with the non-dominant arm and 24 
followed by 70 maximal contractions with the dominant arm. Force generation was assessed 
using the arm curl machine, prior to, immediately following and 5 days after the eccentric trials. 
The results indicated that in all trials strength losses were observed following the eccentric 
exercise bout. However the 70 maximal contraction period with the non-dominant arm declined 
significantly (p<0.01) compared with the other 2 trials. It was observed that for the 24 maximal 
contraction and the second 70 maximal contraction force returned to levels that were not 
significantly different from baseline values and 2 and 4 days respectively. For the non-dominant 
70 maximal contraction phase force remained significantly impaired 5 days following the trial. 
These studies indicate that following eccentric exercise performance will be acutely affected. 
This decline can be attributed to the damage associated with delayed onset muscle soreness, 
which is induced from the eccentric exercise. 
 
Creatine Kinase 
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 In a review by Ebbeling and Clarkson (29), creatine kinase is recognized as being the 
most common indicator of exercise induced muscle damage.  They suggest that it is a marker 
because it is found to be located in the muscle and is released following intense exercise. 
Creatine kinase is the most prevalent in eccentric exercise, which has also been shown to have 
the greatest increase in DOMS. Evans, et al., (24) examined the effects of eccentric exercise in 
trained versus untrained males.  The subjects were 4 trained runners and 5 untrained males, each 
of whom exercised on a cycle ergometer that was designed to mimic eccentric exercise.  Plasma 
creatine kinase was significantly higher in the untrained group compared to the trained group. 
The untrained group displayed creatine kinase levels up to 33 times greater than the obtained 
baseline levels prior to exercise.  Whereas the trained group only experienced increases in 
creatine kinase up to 2.3 times greater than baseline levels.  Creatine kinase levels did not return 
to normal in the untrained group until 9 days following exercise while the trained group’s CK 
levels returned to baseline 2 days after exercise. It was apparent that muscle soreness and 
decreased mobility was evident in the untrained group following exercise.  In addition, creatine 
kinase was significantly higher in the untrained group than the trained group suggesting that it is 
a useful measure in identifying D.O.M.S.   
 Studies show that levels of creatine kinase have been shown to peak 48 hours following 
eccentric exercise. Mair et al. (28) examined the effects of eccentric exercise on muscle soreness 
and creatine kinase. They randomly allocated 22 college age males into two groups, which 
performed two identical bouts of exercise. Group A had two sessions which were separated by 4 
days and group B had two sessions separated by 13 days.  Creatine kinase levels increased 
significantly (p=0.0001) peaking 2 to 3 days following the first bout of exercise in both groups. 
During the second session of eccentric exercise, neither group saw any significant increase in 
creatine kinase suggesting an adaptive effect of the muscle.  Glesson et al. (30)also observed 
significant (p>0.01) increases in CK ranging from 120 to 1950%and peaks occurring from 1, 2, 
3,4, or 7 days following eccentric exercise. 
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In addition, Clarkson and Tremblay (25) report an association between elevated creatine 
kinase levels and soreness following unaccustomed eccentric exercise involving an arm 
ergometer.  Vincent and Vincent (26) show a significant increase (p<0.01) in creatine kinase 
levels in untrained subjects (3272 IU) following exercise when compared to trained individuals 
(1349 IU). However, they report no association between soreness and CK levels because their 
trained group had higher levels of soreness compared to the untrained group.  Suggesting that 
there is a possibility of having an increase in soreness without significantly elevated creatine 
kinase levels. 
There is some question as to how reliable creatine kinase is as a measure of overtraining 
due to inter-subject variability.  Harmann and Mester (31) report enormous differences in both 
men and women athletes with respect to creatine kinase levels.  In addition, they indicate that 
some athletes exhibit low levels of creatine kinase while others demonstrate very high levels 
(31). As a result of this finding it is apparent that it may be difficult to compare creatine kinase in 
a cross-sectional study design. However, a way to alleviate this controversy with respect to 
creatine kinase is to use it in a longitudinal design. In this situation each subject can serve as 
their own control and establish a baseline level to be compared to as proposed in the current 
study.   
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CHAPTER 3 
RESEARCH METHODOLOGY 
 
Subjects 
This study included 32 male subjects who agreed to participate on a volunteer basis.  
Subjects ranged in age from 20-35 years.  In order to be eligible to participate in the study, each 
subject was required to meet the minimum entrance requirements outlined in the delimits of this 
study.  Subjects were required to have a minimum of 4 years of weightlifting experience and had 
to be training at the onset of the study.    All subjects were screened for cardiovascular and 
metabolic related diseases prior to the investigation. Subjects were required to fill out personal, 
medical, demographic, physical activity questionnaires. (Appendix A) If any symptoms were 
observed following the screening process, subjects were excluded from the study.    
 
Research Protocol 
This investigation was conducted using a double blind procedure.  Each subject was assigned an 
identification number and then randomly assigned to receive either the deer antler velvet 
supplement or placebo.  Subjects were required to consume 1500 mg of the supplement 60 
minutes prior to training and 1500 mg following resistance training.  Periodic checks were made 
to count the number of pills in each bottle to ensure that each subject was following the 
supplement regime.  The subjects continued their current resistance protocol, but each was 
required to document each exercise following every workout.  After each subject gave consent to 
participate they were required to complete a series of pretests. Height, weight, and blood 
pressure were obtained first. Maximal Oxygen Uptake (VO2 max) was measured using a graded 
exercise test.  Anaerobic power was measured on the Computrainer cycle system. One repetition 
maximum was obtained for both the bench and squat. Body Composition was assessed using 
Dual energy x-ray absorptiometry (DEXA). Finally the eccentric trial was completed with pre, 
post, and 48 hour blood draws to measure creatine kinase activity. 
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Instrumentation 
 
Maximal Oxygen Uptake 
 Each subject had his maximal aerobic capacity measured on the Quinton 65 treadmill in 
order to assess cardiovascular ability.  A graded exercise test was used to determine maximal 
oxygen uptake and monitor heart function using a 12 lead electrocardiogram (EKG). Upon 
arrival to the ETSU Human Performance Lab, each subject was given instructions as to how the 
treadmill test was performed.  The guidelines outlined by Maud and Foster (32) were used: The 
subject was instructed to lie face up on the prep table. All the landmarks for electrode placement 
using a 12-lead system were located. The landmarks were free of hair and cleaned using alcohol. 
Electrodes were placed on the landmarks, and the subject was hooked to the EKG machine. 
Resting blood pressure and heart rate were recorded in the supine, sitting, and standing positions. 
The subject was instructed to begin walking. In order to measure maximal oxygen uptake (VO2 
max), subjects were connected via a mouthpiece to the SensorMedics 2900 cart.  The connection 
allowed the SensorMedics 2900 to measure the amount oxygen consumed and carbon dioxide 
produced. During the test a rating of perceived exertion was given by the subject and recorded 
every minute.  A 12-lead EKG tracing was taken during the last 10 seconds of each minute and 
heart rate was recorded. Blood pressure was taken every 3 minutes by an experienced technician 
using the Colin STBP-780 electronic blood pressure cuff.  In order for the test to be determined a 
true maximal effort, it was required that specific criteria were met during the exercise bout.  
Maud and Foster (32) outline the criteria as follows; a plateau in VO2 must occur as the workload 
increases, respiratory exchange ratio must exceed 1.1, and heart rate must be within 10 beats of 
the age predicted maximum heart rate. The test was terminated at the request of the subject if the 
subject became dizzy or confused or if EKG problems were detected. 
 
Anaerobic Power 
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 Anaerobic power was measured on the Computrainer cycle system using a test protocol 
designed to serve as a baseline for measuring power (i.e., completing a 0.2 mile flat course as 
quick as possible).  Each subject was instructed to avoid any strenuous exercise 12 hours prior to 
testing.  In addition, each subject had to avoid eating any big meals at least 4 hours prior to 
testing.  The test was performed at the ETSU Human Performance Lab, room 113.  Prior to 
testing, equipment was calibrated at 3.25 lbs of load resistance for each subject’s trials.  After the 
calibration procedure, the subjects were instructed on how to perform the test before beginning 
the protocol, which is outlined as follows: The subject warmed-up at a light intensity for 5 
minutes.  During the test the subject was instructed to remain seated on the bicycle for the 
duration of the test.  The subject began cycling in the 52,23 gear combination at 60 revolutions 
per minute (rpm) for 1 minute in order to obtain a steady state heart rate. The subject continued 
to cycle for another minute while the resistance was increased every 15 seconds. The subject 
then cycled at a maximal effort for 0.2 miles, in the 52, 13 gear. This bout usually lasted between 
25-40 seconds depending on the person.  The subject then rested for 3 minutes, which allowed 
him to recover for the next bout.  This trial was repeated for a second and third trial. If the 
subject experienced dizziness or nausea during the trial the test was terminated. The subject then 
was instructed to cycle lightly until his heart rate returned to less than 100 bpm. The best 
performance of the three trials was used to measure three variables.  The maximum watts, 
average watts, and time to peak power was measured in order to determine anaerobic power (33).   
 
Strength Testing 
Initial strength was determined using a 1-repetition protocol for both bench and leg press. 
All the lifts were performed on the Muscle Maxx  equipment with a spotter present to ensure 
full safety precautions.  The initial weight was estimated based on previous weight lifting 
experience.  A successful attempt involved fully lowering the weight to the chest and then 
extending fully until the arms were straight without any assistance.  This protocol was repeated 
until the subject could no longer lift the weight without assistance from the spotter.  Between 
lifts subjects were given approximately 2-5 minutes of rest to ensure recovery.  One repetition 
maximum (1-RM) was determined using the last successful attempt prior to failure. For the 
maximal squat attempt the subject was instructed to squat until the leg reached a 90 degree angle. 
A spotter stood behind the subject to ensure safety. One repetition maximum was determined 
using the last successful attempt prior to failure. The weight was recorded in pounds and then 
converted to kilograms to the nearest tenth. The total amount of weight was determined by 
adding the 45 lbs bar to the weight of each plate for the bench press and squat. 
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Body Composition 
 Each subject’s body composition profile was assessed by taking height (m), 
weight (kg), body mass index, and DEXA measurements. DEXA measurements were performed 
at The Center for Reproductive Sciences in Johnson City, Tennessee. The subjects were required 
to remove all jewelry and shoes during the scan.  The subjects were instructed to lie straight and 
still on the table while the scan takes place. The top of the subject’s head was positioned 0.05 
inches from the edge of the table to ensure that the whole head was included in the scan.  The 
subject’s feet and knees were secured with velcro straps to the table.  The same technician 
conducted all the scans to ensure reliability during the investigation.  From the DEXA measures, 
each subject’s body fat percentage, fat weight, fat free weight, and trunk-to-limb ratio were 
determined. 
 
Eccentric Trial 
As mentioned previously, DOMS is most prevalent with eccentric related exercises.  
Therefore, in order to induce DOMS it was necessary to concentrate primarily on eccentric type 
exercises when designing the overtraining protocol. The purpose of the eccentric trial was to 
determine if deer antler velvet could enhance recovery time and performance at 70% of max 
lifting to high intensity resistance training.  This was accomplished by having each subject 
complete a series of resistance based exercises as outline in Table 2 and evaluated for markers of 
DOMS (pain rating scales, creatine kinase) before, immediately after, and 48-hours post the 
eccentric exercise trials.  Subjects had their blood drawn by a licensed phlebotamist at the ETSU 
Human Performance Lab immediately before beginning the eccentric protocol. The investigators 
ensured that each subject was ready to participate in the trial after giving blood (ie check for 
blood clotting and dizziness).  The subjects were escorted to the varsity weight room at ETSU to 
participate in the trial.  The trial was explained thoroughly by the investigator to ensure that each 
subject understood each exercise.  Subjects were grouped according to similarities in bench press 
and leg squat in order to limit the time it takes to load the weight on to the racks. Each subject 
focused on upper body and then lower body exercises. The upper and lower body exercises are 
presented in Table 2 below: 
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Table 2. Eccentric Trial Exercise Protocol 
Upper Body Exercises Weight Repetitions Sets 
Bench Press Based on 70% of pre-
determined 1-RM 
Until Failure, no longer being 
able to lift the weight 
3 
Smith Machine 
Negatives 
Based on 10% > than pre-
determined 1-RM 
Until Failure, no longer being 
able to keep with the cadence 
3 
Push-ups Body Weight Until failure, no longer able to 
propel self upward 
3 
Lower Body Exercises    
Squats Based on 70% of pre-
determined 1-RM 
Until failure, no longer being 
able to lift the weight 
3 
Medicine Ball Jumps 10 lbs medicine ball Until Failure, can no longer 
jump and hold weight over 
head 
3 
Box Jumps Body weight Until Failure, can no longer 
jump onto the box 
 
*see appendix B for a complete trial description 
The upper body exercise protocol began with the bench press as shown in appendix B. 
The weight used for the bench press was calculated at 70% of each person’s predetermined 1-
RM. Bench press exercises were performed to fatigue. This was defined as the inability to 
continue to lift the pre-determined weight. A spotter was present in order to ensure safety 
precautions. Smith machine negatives were performed on a smith machine, which allowed the 
subjects to safely lift very heavy resistance.  The weight that each subject lifted was based on 
greater than 10% of his predetermined 1-RM for the bench press.  Each subject lowered the bar 
in conjunction with a specific cadence that was counted out by the spotter, which was 
approximately 3 seconds/repetition. Then the bar was raised up by spotters in order to 
specifically focus on eccentric loading.  Fatigue was defined as that point in which the subject 
could no longer maintain the 3 seconds/repetition cadence. Push-ups were repeated until fatigue, 
which was defined as the inability to continue propelling the body up and down. The subjects 
placed their hands and feet on a mat for comfort. 
 The lower body exercises involved squats, medicine ball jumps, and box jumps.  Squat 
weight was calculated based on 70% of each person’s pre-determined 1-RM for the squat 
exercise before initiating the protocol.  Squats, shown in appendix B, were performed to fatigue 
with a spotter present for safety.  The medicine ball jumps, shown in appendix B, involved 
beginning in a squat position while holding onto the medicine ball.  The subject jumped into the 
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air while hoisting the ball above his head.  Then the subject landed in the squat position, again 
focusing on eccentric loading. This was repeated until fatigue, which was defined as being 
unable to lift the ball directly above the subject’s head. Also, the inability to jump off the ground 
ended the trial.  Finally, box jumps shown in appendix B, were performed on a 12-inch box.  
Each subject began on the floor and stepped onto the box, alternating which foot he stepped up 
with.  When the subject reached the top of the box he stepped off the box into a squat position 
and jumped as high as he could landing on two feet.  This was repeated until fatigue, which is 
defined as no longer being able to successfully step up onto the box. 
 The protocol was as follows: a) the subject began with upper body exercises; b) the 
subject completed the sets until failure of each upper body exercise without any rest in between 
exercises or sets; c) the subject was timed on each exercise and the times and number of 
repetitions were recorded; d) this circuit was repeated 3 times; e) after completing upper body, 
the subject completed the 3 lower body exercises; f) the exact same sequence occurred with the 
lower body protocol. Refer to appendix B. 
 Following completion of the eccentric trial, the subjects were required to give another 
blood sample. This blood draw occurred 5 minutes after the trial finished. Subjects were 
scheduled to return to the Human Performance Lab exactly 48 hours following the last blood 
draw. Another sample of blood was drawn to measure creatine kinase.  Following the blood 
draw, subjects completed a 70% trial involving bench press and squat to measure performance.  
Each subject exercised at 70% of his pre-determined 1-RM.  The trials were timed, and the 
number of repetitions was counted with a spotter present to ensure safety.  After the eccentric 
trial subjects were given either supplement or placebo. 
 
Perceived Soreness Scale 
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 A subjective pain scale was used in order to assess perceived levels of soreness following 
the eccentric trial.  A baseline measure was obtained by administering the scale prior to initiating 
the eccentric trial.  Additional measures were obtained immediately post, 24, and 48 hours 
following the completion of the trial. Each subject was asked to rate soreness from a scale of 0-
10 (0=none, 10=excruciating) as shown in appendix C. Soreness was assessed in the following 
areas: neck, shoulders, upper back, triceps, biceps, chest, abdomen, forearms, lower back, 
buttocks, hips, groin, hamstring, quadriceps, calf muscle, and shins.  
 Performance Trial 
 Subjects returned 48 hours after the completion of the eccentric trial to assess muscular 
performance after muscle damaging exercise.  Muscular performance was assessed by comparing 
each subject’s ability to lift 70% of his 1-RM values for the bench press and squat lifting results 
before and after 10 weeks with and without oral deer antler velvet supplementation. Muscular 
performance was also assessed based on the number reps/sec. 
 
Assay Procedure 
In order to analyze and compare the levels of serum creatine kinase between the subjects 
in both the supplement and placebo groups, specific assays were performed.  The guidelines 
necessary for creatine kinase analysis are outlined by Sigma Diagnostics as follows: a). 2 
different test tubes were labeled, Test and Blank, and the appropriate solutions were pipetted into 
each one.  In the tube labeled “test” 1.0 ml of Creatine Solution, Catalog No 661-6, 0.3 ml of 
Serum and 1.0 ml of Water was pipetted. In the Blank tube 1.0 ml TRIZMA  Buffer Solution, 
0.3 ml of Serum and 1.0 ml of water was pipetted. B) Both tubes were then placed into a 37° C 
for a 5 minutes. c) After the tubes were warmed, 0.10 ml of ATP-Glutathione Solution was 
added and incubated for 30 minutes. d) After incubation, 1.6 ml of cold Trichloroacetic Acid was 
added to stop the reaction. e) After 5 minutes the tubes were centrifuged to obtain clear 
supernatant or filter through the ashless filter paper. f) Then 2 cuvets were labelled “blank” and 
“test” which received 1.0 ml of clear supernatant from the corresponding tube. g) Each tube 
received 4.0 ml of water, 1.0 ml of Acid Molybdate Solution and 0.25 mL Fiske and SubbaRow 
Solution. h) After the mixture was added, each tube was left to stand for 30 minutes at room 
temperature (18° C-26°C) while the phophocreatine (CPK) hydrolyzed and color developed. I) 
The solutions were then transferred no later than 10 minutes into cuvets, in order to read and 
record the absorbance levels using a mass spectrophotometer. j) The µg P for the Test and Blank 
cuvets was determined. k) Then both numbers were subtracted in order to determine the change 
in µg P. l) CPK was determined using the values from Sigma Diagnostics.   
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 Statistical Analysis 
All data are presented as means ± standard deviations. Repeated measures analysis of 
variance was used for all analysis.  For example, the effects of deer antler velvet on VO2 max 
used a 2 x 2 repeated measures ANOVA (1 between variable = supplement versus placebo and 1 
within variable = pre versus post measurement).  When a significant Group * Measurement 
period interaction was observed (p<.05), a Student-Neuman-Keuls post Hoc procedure was used 
looking at the individual groups. All statistical procedures were performed using Statview 
Statistical Software (SAS Institute).  
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CHAPTER 4 
RESULTS 
Sixteen subjects from the original 32 were excluded from the final data pool due to the 
following reasons.  There were six subjects who completed the initial testing procedures but did 
not participate in the eccentric trial. Six subjects were excluded due to lack of compliance 
regarding experiment protocol. Of those six, three failed to complete the 5-week testing 
requirements and three did not adhere to the guidelines regarding supplement ingestion. Two 
subjects dropped out as a result of time constraints with work and school. One subject dropped 
out due to an unrelated injury. Finally, one subject dropped out because he wanted to drastically 
alter his workout regime, which fell outside the study guidelines. 
The final data pool consisted of 16 participants, who were randomly allocated into either 
the Deer Antler Group (n=8) or the placebo group (n=8). 
  
Baseline Characteristics 
 There were no observed significant differences (p>0.05) between or within the groups at 
0 or 10-week measurements, regarding age, height, weight, or body mass index (BMI) as 
reported in Table 3. The values for BMI indicate the presence of grade 1 and 2 obesity for both 
group B and A respectively; however, both groups are considered a special population therefore 
excluding BMI as a valid predictor of obesity. This fact is supported by the DEXA percent body 
fat data showing that each group should be classified as borderline obese only (ie. % body fat 
between 20.0%- 24.9%) 
 Following the 10-week intervention period, alterations in DEXA % body fat, DEXA fat 
free weight, and trunk-to-limb fat weight ratios were observed as indicated in Table 3.  In the 
deer antler velvet group, DEXA percent body fat declined from 21.7 ± 6.5 to 20.2 ± 6.2% 
(p=0.08) while DEXA fat free weight increased 76.8 ± 7.8 kg to 77.6 ± 7.6 kg (p=0.08).  In the 
placebo group, the decline in DEXA % body fat neared significance (0-weeks = 20.0 ± 5.2% to 
10 weeks = 18.7 ± 4.5%; p=0.06), while fat free weight significantly increased 0 to 10 weeks 
following treatment (0-weeks = 74.8 ± 8.6 kg to 10 weeks = 76.3 ± 8.6 kg; p=0.03). In addition, 
a significant reduction in the trunk to limb ratio of 2.75% was observed (p=0.03) in the placebo 
group only. 
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Table 3. Subject Characteristics 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
Age 26.6± 2.2 • 24.3± 2.8 • 
Height (m) 1.78 ± 0.0 • 1.81 ± 0.1 • 
Weight (kg) 99.1 ± 15.9 98.2 ± 15.1 93.6 ± 10.0 94.0 ± 10.5 
BMI 31.1 ± 4.4 30.8 ± 4.0 28.7 ± 2.7 28.8 ± 2.8 
Dexa %BF 21.7 ± 6.5 20.2 ± 6.2 ¥ 20.0 ± 5.2 18.7 ± 4.5 φ 
Dexa FW (kg) 22.3 ± 8.8 20.5 ± 8.1 18.8 ± 5.7 17.7 ± 5.1 
Dexa FFW (kg) 76.8 ± 7.8 77.6 ± 7.6 ¥ 74.8 ± 8.6 76.3 ± 8.6 π 
Trunk to Limb FW Ratio 109.8 ± 31.4 110.3 ± 30.1 102.0 ± 27.3 99.2 ± 25.8 π 
¥= significantly different from pre-training values within the supplement group p = 0.08; φ= significantly different 
from pre-training values within the placebo group p=0.06; π = significantly different from pre-training values within 
the placebo group p=0.03. 
 
Aerobic and Anaerobic Assessments 
When examining the aerobic and anaerobic variables shown in Table 4, there were no 
reported response differences between the treatment and placebo groups following the treatment 
period. However, there was a significant p < 0.0040 increase in relative and absolute VO2 max 
(47.0 ± 8.6 to 50.0 ± 9.5 ml.kg.min-1, 4.3 ± 0.5 to 4.7 ± 0.6 l.min-1) for the placebo group 
following the 10-week intervention.  For the anaerobic power measures (peak power, time-to-
peak power, peak power/fat free weight (kg), average power/ fat free weight (kg)) no significant 
changes occurred in either group following the treatment period.  However, it is important to 
point out that although peak and average power showed small declines in the placebo group, time 
to peak power declined 13.9 %.  These data suggest that the placebo group improved their ability 
to generate peak force more quickly. 
 38
Table 4: Aerobic and Anaerobic Results 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
VO2 Max ml.kg.min-1 43.1 ± 7.4 43.7 ± 8.4 47.0 ± 8.6 50.0 ± 9.5 ¥ 
VO2 Max l.min-1 4.0 ± 0.5 4.2 ± 0.5 4.3 ± 0.5 4.7 ± 0.6 ¥ 
Peak Power (watts) 726.4 ± 175.9 715.1 ± 167.7 772.6 ± 139.5 766.8 ± 156.2 
Average Power (watts) 571.3 ± 106.9 571.4 ± 122.3 612.9 ± 106.2  603.6 ± 108.0 
Time to Peak Power (secs) 6.9 ± 2.24 6.86 ± 1.79 8.06 ± 2.78 6.94 ± 1.50 
Peak Power (W) 726.4 ± 175.9 715.1 ± 167.7 772.6 ± 139.5 766.8 ± 156.2 
Average Power (W/0.22 kms) 571.3 ± 106.9 571.4 ± 122.3 612.9 ± 106.2 603.6 ± 108.0 
¥ =significantly different from pre-training relative and absolute VO2 max values within the placebo group p < 
0.0040 
 
1 RM, Lift Performance @ 70% of Max, and Markers of Eccentric Muscle Damage 
 Following the 10- week intervention, both absolute bench press and squat max weight 
lifted increased significantly (p < 0.05) for both groups as shown in Figures 3 and 4. However, 
there were no significant differences in treatment responses between the supplement and placebo 
groups from 0 to 10 weeks. 
 The best performance for both the bench press and squat were analyzed to determine if 
deer antler velvet had any effect on muscular lift performance before and 48 hours after the 
eccentric exercise trials. There were no significant differences regarding weight lifted per second 
between the groups, 0 to 10 weeks for the bench press. The were no significant differences for 
the bench press performance observed within the supplement group at 0 to 10 weeks following 
treatment from baseline to 48 hours following the eccentric trial. At 0-weeks there were no 
significant differences within the placebo group for the bench press weight lifted per second 
performance. Post-treatment the placebo group lifted significantly (p=0.02) less weight per 
second (109.9 ± 30.82 to 88.17 ± 20.43) for the bench press from baseline to 48 hours following 
the eccentric trial. 
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1-RM Results: Bench Press (kg)  
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Figure 3: 1-RM Results: Bench Press (kg) 
*= significantly different from pre-training values within the 
supplement group p=0.0040; ^ =significantly different from pre-
training values within the placebo group p=0.0020. 
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1-RM Results: Squat (kg)
 
^
*
140
145
150
155
160
165
170
175
180
DAV Placebo
Group
Pre
Post
Figure 4: 1-RM Results: Squat (kg) 
*= significantly different from pre-training values within the supplement group 
p=0.0040; ^ = significantly different from pre-training values within the 
placebo group p=0.0020. 
 
 
Muscular performance was measured by determining each person’s lifting weights equal 
to 70% of his 1-RM bench and squat value as many times as possible as shown in the following 
formula. 
Muscular Performance =
Total number of repetitions * 70% of 1- RM (kg)
Total Lift Time (sec)
 
As reported in tables 5 and 6 there were no significant group differences prior to and 
following the treatment period.  The placebo group did show significant improvement in the 
amount of weight lifted/second for the squat compared to the pretreatment period.  This resulted 
in a 9.7% improvement. 
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Table 5: Pre-Eccentric Performance (Best Trial): Bench 
 Deer Antler Supplement Placebo 
Variable Pretreatment Posttreatment Pretreatment Posttreatment 
Bench Press (kg) @ 70% 
1-RM 
89.8 ± 15.0 93.5 ± 16.8 82.47 ± 17.3 87.01 ± 19.9 
Total Weight Lifted (kg) 1330.7 ± 223.2 1224.4 ± 183.7 1242.2 ± 197.0 1209.4 ± 297.8 
Wt Lifted / Second 
(kg/sec) 
46.7 ± 19.8 38.4 ± 11.4 44.9 ± 13.9  50.0 ± 14 
*no differences for any of the variables 
 
 
Table 6: Pre-Eccentric Performance (Best Trial): Squat 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
Squat Wt (kg) @ 70% 1-RM 108.2 ± 18.4 113.9 ± 19.5 112.7 ± 34. 124.0 ± 35.0 
Total Weight Lifted (kg) 1281.0 ± 395.1 1203.7 ± 341.8 1696.4 ± 560.8 1644.5 ± 616.8 
Wt Lifted / Second (kg/sec) 32.18 ± 6.6 33.0 ± 6.2 36.4 ± 13.5 39.9 ± 13.0 §  
§: significantly different (p=0.06)from pre value at week 10 
 
For both the bench and squat measurements @ 70% of max, there was a decline in the 
amount of weight lifted in absolute weight and weight per second 48 hours following the 
eccentric trial which is shown in Figures 5 and 6 below.  The supplement group declined 21.5% 
whereas the placebo group declined 11.1% for the bench press from 0 to 10 weeks of the 
eccentric trial for the total amount of weight lifted. The squat indicated positive changes in the 
deer antler velvet group (10.2 %) whereas the placebo group declined 13.4 %, which was 
significantly (p=0.05) different between the two groups for the total amount of weight lifted. The 
total amount of weight lifted per second indicated no significant differences between the groups 
at 0 and 10 weeks of the eccentric trial.  
Table 7: 70% Bench Performance 48 hour Post Eccentric Trial 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
Total Weight Lifted (kg) 1105.4 ± 317.5 896.9 ± 361.8 1110.4 ± 138.2 1068.5 ± 277.5 
Wt Lifted / Second (kg/sec) 43.7 ± 9.1 40.2 ± 9.1 39.7 ± 10.3  40.1 ± 9.3 
*no differences for any of the variables 
Table 8: 70% Squat Performance 48 hour Post Eccentric Trial 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
Total Weight Lifted (kg) 1447.5 ± 502.6 1295.5 ± 522 1401.6 ± 372.3 1490.6 ± 376.8 
Wt Lifted / Second (kg/sec) 31.3 ± 6.4 32 ± 4.9 35.1 ± 11 41.0 ± 14.6 
*no differences for any of the variables 
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 Figure 5: Percent Change in Total Weight Lifted (kg) Pre to Post-Treatment 
               **= significantly different from pre to post eccentric trial within the          
               groups. 
 43
 -6.5%
-15.7%
-3.0%
-0.4%
-16.0%
-14.0%
-12.0%
-10.0%
-8.0%
-6.0%
-4.0%
-2.0%
0.0%
%
 C
ha
ng
e 
in
 T
ot
al
 W
T 
Li
fte
d 
(k
g)
Bench Squat
Exercises
DAV
Placebo
Figure 6: Percent Change in Total Weight Lifted Per Second Pre to Post-Treatment 
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Creatine Kinase Assessment 
After completion of the eccentric trial at 0 and 10 weeks, there was an expected 
significant (p<0.05) rise in creatine kinase values for both the supplement and placebo groups, 
which is indicated in Table 9. There were no significant differences between the groups at 0 and 
10 weeks following the intervention. There were no significant differences within the groups at 0 
and 10 weeks except at the 48-hour measurement period. The placebo group showed a 
significant decrease (p<0.05) in creatine kinase values (53.6 ± 42.0 to 33.4 ± 40.9 sigma units) 
when compared to the supplement group at week 10, 48 hours post-eccentric trial. 
Table 9: Creatine Kinase Values 
 Deer Antler Supplement Placebo 
Variable 0 weeks 10 weeks 0 weeks 10 weeks 
Pre Eccentric Trial 14.6 ± 14.0 12.6 ± 19.0 11.3 ± 11.0 7.7 ± 6.0 
Immediately Post 27.0 ± 23.0 ¥  23.3 ± 17.9 ¥ 49.4 ± 50.0 ¥ 21.3 ± 14.9 ¥ 
48 hr Post 34.2 ± 33.1 ¥ 20.1 ± 13.6 ¥ 53.6 ± 42.0 ¥ 33.4 ± 40.9 ¥,* 
¥ = Significantly different from Pre eccentric trial; * No significant differences between the group responses except 
at 48 hr post in group B in which CK was significantly less than pretreatment values (p=0.02). 
 
Measures of Soreness 
 Following the eccentric trial levels of soreness were evaluated by each subject pre, 
immediate post, and 48 hours post at both 0 and 10 weeks. A sum total of each of the variables 
was calculated from the soreness questionnaires, and the mean was calculated in order to 
compare the placebo and supplement groups. The variables analyzed were neck, deltoids, triceps, 
biceps, chest, abdomen, quadriceps, hamstrings, buttocks, calves, and shins. When the two 
groups were compared, there were no significant differences between the groups at 0 and 10 
weeks for any of the measurement periods. However, when each group was analyzed 
individually, there were significant differences with respect to levels of soreness. At 0 weeks the 
deer antler velvet group reported a soreness level of 16.14 ± 8.07 prior to the eccentric trial. 
Immediately after the eccentric, trial soreness levels increased to 33.4 ± 19.8. The soreness levels 
then significantly increased to 34.9 ± 18.4 (p= 0.05) 48 hours following the trial, which is 
indicated in Table 10 below. Similar results were observed following the 10-week 
supplementation period. Soreness levels significantly increased immediately following the trial 
from 8.1 ± 6.7 to 22.9 ± 14.0 (p=0.05) and then continued to rise to 39.0 ± 18.7, 48 hours after. 
The soreness levels reported at 48 hours were significantly higher from pre values and post 
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values. At 0 weeks, the placebo group reported a soreness level of 11.4 ± 17.8 which then 
continued to increase to a level of 45.0 ± 34.3, which was significantly (p=0.05) higher.  
Soreness continued to significantly increase (p=0.05) from pre to 48hrs (48.3 ± 26.6) after 
completion of the eccentric trial. At 10 weeks there were similar reported significant increases 
between measurement periods. Soreness levels before the trial began were reported at 14.3 ± 
12.6, they continued to increase to 46.9 ± 30.0 immediate post and then continued rising to 59.3 
± 40.5, 48 hours after.  
Table 10: Soreness Scale Values 
 deer antler velvet Group Placebo Group 
Measurement Periods 0 Weeks 10 Weeks 0 Weeks 10 Weeks 
Pre 16.1 ± 8.1 8.1 ± 6.7  11.4 ± 17.8 14.3 ± 12.6  
Immediate Post 33.4 ± 19.8 ¥ 22.9 ± 14.0 ß 45.00 ± 34.32 ¢ 46.9 ± 30.0 § 
48 Hours Post 34.9 ± 18.4 ¥ 39.0 ± 18.7 ß £ 48.3 ± 26.6 ¢ 59.3 ± 40.5 § 
¥ = significantly different from pre eccentric trial at 0 weeks p=0.05 ß= significantly different from pre values at 10 
weeks p=0.05 £ = significantly different from immediate post at 10 weeks p= 0.05. ¢ = significantly different from 
pre-eccentric trial at 0 weeks p=0.05. § = significantly different from pre-eccentric trial at 10 weeks p=0.05. 
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CHAPTER 5 
SUMMARY, DISCUSSION AND RECOMMENDATIONS 
 
Summary of Findings 
 The purpose of this study was to examine the effects of deer antler velvet on maximal 
strength, muscular performance, muscular performance recovery, and markers of delayed onset 
of muscle soreness (DOMS) in resistance trained men 18 to 35 years old with at least 4 years 
experience. Using a double blind administration protocol, subjects were assigned either 
supplement or placebo and continued a regular workout regiment for a 10-week duration.  
 The study’s results indicate that any improvements in maximal strength, power, 
performance, or recovery time following a workout were not from oral ingestion of deer antler 
velvet. These findings were not consistent with those reported by the New Zealand in-house 
report.  The report detected trends toward increases in strength measures that were higher in the 
supplement group than the placebo group. Thus indicating that velvet antler may have beneficial 
effects with regards to strength improvements. 
 
Discussion 
 
Body Composition Findings 
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 Fat free weight, fat weight, and percent body fat was assessed using DEXA. There were 
no significant differences between the groups with regards to body composition. Both groups 
indicated strong trends towards increases in fat free weight and decreases in percent body fat. 
The placebo group had significant improvements in fat free weight (pre = 74.8 ± 8.6 kg to post = 
76.3 ± 8.6 kg; p=0.03) following the 10-week intervention period.  These findings demonstrate 
that supplementing deer antler velvet with weight training provides no evidence of ergogenic 
benefits. These findings were similar to the values observed by Agresearch from a preliminary 
pilot study. They also observed strong trends regarding reductions in fat weight and percent body 
fat as measured using the DEXA technique. However, the New Zealand report was unable to 
distinguish whether or not the positive effects could be attributed to the deer antler velvet or the 
training regiment.   This study provides additional support that deer antler velvet does not 
contribute to improvements in body composition because the placebo group showed significant 
increases in fat free weight whereas the supplement group only demonstrated a strong trend. 
Evidence indicates that following resistance training, subjects reduce body fat percentage and 
increase overall muscle size. An investigation conducted by McCall et al. (2) indicates that fat 
free mass and cross-sectional muscle hypertrophy improves as a result of continual resistance 
training without supplementation usage. Thus, these results combined with the Agresearch report 
show that deer antler velvet does not provide an ergogenic benefit regarding body composition 
during resistance training. 
 
Anaerobic and Strength Findings 
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 The results of this study did not give any indication that deer antler velvet could increase 
power. There were no significant differences between or within the groups regarding an increase 
in power output following the intervention. A New Zealand in-house report found no significant 
increases in peak or average power output with subjects who had undergone 10 weeks of 
strength training while ingesting deer antler velvet or placebo. A t-test was used of absolute 
change in each measured power variable. Based on the number of subjects in the New Zealand 
based study, a t-test value greater than 2.1 indicated a significant change. Both peak power and 
average power exhibited a t value of 0.1. Those subjects were ingesting 70 mg per day of deer 
antler velvet. In the current study subjects were ingesting 1500 mg per day of deer antler velvet. 
Despite a 21-fold increase in supplement dosage per day, no significant changes in power were 
observed. These results strongly suggest that deer antler velvet supplementation provides no 
ergogenic benefits on power related performance. This investigation disproves anecdotal theories 
that deer antler velvet may have ergogenic benefits with respect to power output. This is 
especially true when one considers how power was tested in the current study. Unlike the 1-RM 
testing procedures, power was tested using a special cycle ergometer system designed by 
Computrainer. Unlike the 1-RM tests (i.e., bench press and squat), subjects only performed the 
cycle ergometer power testing procedures during orientation session, in the 0-week, and 10 week 
testing periods. Thus, if deer antler velvet supplementation indeed improves power related 
performance, it could not be related to a training effect. This is in stark contrast to the 1-RM tests 
in that each person’s training sessions include both exercises, which might explain why each 
group showed significant improvements in max bench and squat performance as described 
below. 
This study showed that both groups demonstrated increases in strength because 1-RM for 
bench and squat values significantly improved within both groups. However, these 
improvements cannot be attributed to supplementation, rather the increases were a direct result of 
weight training for 10 weeks. Studies show that following a resistance training period, subjects 
show significant increases in strength measures. An investigation by Staron et al., (34) reported 
significant increases (p< 0.05) in leg extension and squat for both men and women following an 
8-week progressive resistance training program. Hickson et al. (35) reported a 22% significant 
increase in bench press and a 29% significant increase in squat for an 8-week training protocol. 
Finally, Mazzetti et al. (36) examined the effects of supervised versus non-supervised weight 
training for 12 weeks on males ages 18-35. They reported that although the supervised group had 
significantly (p<0.05) higher increases in bench and squat for 1-RM, both groups showed 
significant improvements from pre to post intervention similar to those observed in the current 
study.  
 
Aerobic Findings 
Although the subjects were not specifically training to enhance their aerobic capacity, 
measurements of VO2 max were taken in order to monitor aerobic capacity. It is believed that 
deer antler velvet may have cardiovascular benefits. Kim et al., (6) indicated a significantly 
higher hemoglobin and erythrocyte count in rabbits treated with deer antler velvet when 
compared with those treated with placebo. The results of this study disprove the theory that deer 
antler velvet may enhance aerobic capacity because there was no significant increase regarding 
VO2 max, hemoglobin, and hematocrit in the supplement group.  There was, however, a 
significant increase in relative and absolute VO2 max (47.0 ± 8.6 to 50.0 ± 9.5 ml.kg.min-1, 4.3 ± 
0.5 to 4.7 ± 0.6 l.min-1, p < 0.0040) for the placebo group following the 10-week intervention. It 
has been suggested that resistance training alone may enhance aerobic capacity. However, 
according to Baechle and Earle (37) these improvements are only observed in untrained 
individuals. A study by Kraemer (38) indicates that following resistance training no 
improvements in VO2 max were observed in trained males. Thirty-five males were recruited 
from the army to participate in the study. Subjects were randomly allocated into 1 of 4 groups, 
which included, an endurance training group (E), strength group (ST), a combined strength and 
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endurance trained group, and an upper body strength and endurance trained group (UC). The 
results indicated that when resistance training was combined with endurance training VO2 max 
improved significantly (p<0.05) in both the C and UC groups (58.88 ± 5.95 to 63.41 ± 8.02, 
51.43 ± 6.92 to 51.43 ± 6.92 to 56.38 ± 4.69 respectively). However, the subjects who were in 
the strength group did not indicate any improvement in VO2 max following the 12-week training 
period (53.47 ± 4.95 to 53.02 ± 4.34). This study may support the findings of the current 
investigation, because the only improvements that were observed were in the placebo group. 
Possible explanations may be that the placebo group could have incorporated more aerobic 
exercise than the supplement group. However, according to the exercise training logs, this 
change could not be attributed to an increase in aerobic exercise training.  It cannot be 
discounted that the subjects did not properly report any increases in aerobic training. Another 
possible explanation could be due to improve mechanical efficiency within the placebo group. 
They demonstrated a greater increase in lower body strength although not significantly different 
from the supplement group. As mentioned previously, this effect has only been observed in 
untrained individuals and has not yet been demonstrated with trained individuals, similar to the 
subjects in this investigation. 
 
Performance Findings 
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 There were no significant improvements found in any of the 70% performance trials, 
which analyzed bench press and squat following the eccentric trial. These findings are consistent 
with those reported in a review by McIntyre, Reid, and McKenzie (22) which indicates that 
Clarkson and colleagues demonstrate strength losses following eccentric exercise that may be 
attributed to overstretched sarcomeres which could affect force production (22).  In addition, 
McIntyre et al., (22) support findings by Faulkner and colleagues who state that some sarcomeres 
may stay the same while others are stretched causing damage.  As a result, one would expect the 
amount of weight a person could lift per unit of time to decline as occurred in the current 
investigation. Studies have shown that performance following eccentric exercise declines as a 
result of the damage associated with DOMS. A study by Mair and colleagues (28) examined the 
effects of eccentric exercise on 22 male volunteers from a physical education class that ranged in 
age from 20 to 26 years. Performance was tested using the Kistler force platform where the 
subjects performed one-legged vertical jumps, which measured force production and vertical 
jump height. This test was completed before, immediately after, 1, 2, 3,and 4 days following the 
eccentric exercise for both groups. The results indicated that there was a significant (p=0.0001) 
decline in force production following the exercise bout for both groups.  The most pronounced 
decline was observed immediately following however, performance remained affected up to 4 
days after the eccentric trial.  A study by Vincent and Vincent (26) demonstrates reductions in 
performance following resistance exercise.  Force during extension and flexion of the knee was 
measured using an isovelocity dynamometer before, immediately after, 1, 2, 3, 4, 5, 6, and 10 
days following the resistance exercise. During the knee extension phase, the baseline value for 
the trained group was 365 ± 83 Nm, the baseline value for the untrained group was 316 ± 34 Nm. 
Both the trained and untrained group demonstrated a significant (p<0.05) reduction (30% and 
24% respectively) in isometric peak torque capacity immediately following the exercise. During 
the knee flexion phase, the baseline value for the trained group was 167 ± 11 Nm; the baseline 
value for the untrained group was 163 ± 13 Nm.  Again there was a significant decrease (p<0.05) 
in isometric peak torque capacity for both groups (Trained= 25%, Untrained = 17%) following 
the exercise bout.  The findings regarding performance are consistent with those of the current 
study, which indicated that both groups demonstrated a significant decline in performance 48 
hours following the eccentric trial.  
 
Creatine Kinase Findings 
Ebbeling and Clarkson’s (29) review defines creatine kinase as the most common 
indicator of muscle damage because it is released after strenuous exercise. As a result creatine 
kinase was use as a marker of DOMS for this investigation. 
After completion of the eccentric trial at 0 and 10 weeks, there was a significant (p<0.05) 
rise in creatine kinase values for both the supplement and placebo groups. There were no 
significant differences between the groups from 0 to 10 weeks following the intervention. The 
only significant differences within the groups was observed in the placebo group which reported 
a significant decline (p<0.05) in creatine kinase values (53.6 ± 42.0 to 33.4 ± 40.9 sigma units) 
from week 0 to week 10, 48 hours post-eccentric trial.   
These findings are consistent with evidence shown in similar studies that used eccentric 
trials as a means to increase creatine kinase and measure overall muscle damage.  It has been 
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proven that following eccentric exercise delayed onset muscle soreness and creatine kinase will 
increase. Evans et al. (24) indicate that creatine kinase levels peak 24-48 hours and continue to 
increase up to 5 days after the exercise in trained and untrained subjects. These findings are 
similar to the current investigation, which indicated significant increases in creatine kinase 48 
hours following eccentric exercise. In addition, Mair et al. (28) examined the effects of eccentric 
exercise on muscle soreness and creatine kinase. They randomly allocated 22 college age males 
into two groups, which performed two identical bouts of exercise. Group A had two sessions 
which were separated by 4 days and group B had two sessions separated by 13 days.  Creatine 
kinase levels increased significantly (p=0.0001) peaking 2 to 3 days following the first bout of 
exercise in both groups. They reported significant (p<0.0001) increases in creatine kinase 
activity, which peaked 48-72 hours following the eccentric trial. Again, the findings are 
consistent with the current study, which also used college-aged males to measure creatine kinase 
following an eccentric exercise. Glesson et al.(30) also observed significant (p<0.01) increases 
and peaks in creatine kinase ranging from 1, 2, 3,4, or 7 days following eccentric exercise. 
Clarkson and Tremblay (25) report evidence that following repeated bouts of eccentric exercise, 
muscles experience an adaptation effect regarding delayed onset muscle soreness and creatine 
kinase.  
 Although not significant, during the 10-week measurement period the supplement group 
actually started a small decline in creatine kinase levels immediately post to 48 hours post (23.3 
± 17.9 to 20.1 ± 13.6). This was the only measurement period that creatine kinase levels showed 
a slight decrease. All other measurement indicated increases from pre to 48 hours following the 
eccentric trial. These findings may suggest that deer antler velvet may have some anti-
inflammatory properties as indicated by the Agresearch in-house report (6). 
 
 
 
Soreness Scale Findings 
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Both groups reported significant increases in levels of soreness immediately post and 48-
hours following the eccentric trial at 0-weeks and 10 weeks. These findings are consistent with 
those reported by Stauber, Clarkson, Fritz and Evans (23). They indicated that soreness levels 
increased from 1 to 8 on a scale of 10, 48 hours after exercise. Gleeson et al. (30) used a self-
reported soreness scale and observed complaints of maximal soreness 48 hours following 
eccentric exercise. Finally a study by Nosaka, Sakamoto, Newton and Sacco (39) also indicates 
that soreness levels peaked 24-48 hours following unaccustomed eccentric exercise. 
It has also been reported that delayed onset muscle soreness will decrease as a result of 
the muscle experiencing an adaptive effect to unaccustomed exercise. The results of this study 
did not produce an adaptive effect between the two eccentric trials. Reported soreness levels 
were the same within groups and between the groups at 0 and 10 weeks of the intervention. 
These findings are different than those reported by Clarkson and Tremblay (25) that found that 
following recovery from DOMS, the muscle tissue was able to heal and make adaptations in 
order to prevent future injury. When eccentric exercise was repeated the level of creatine kinase 
and the amount of muscle soreness significantly diminished during the repeated bout of exercise 
when compared to the initial bout. 
 
Recommendations for Future Research 
It is recommended that: 
1. A similar study be conducted using either a specific training protocol or a monitored    
training regiment with college aged males with at least 4 years weight lifting   
      experience. 
2. A similar study be conducted that monitors dietary intake specifically protein     
consumption.  
3. A similar study be conducted that monitors creatine kinase and soreness 7 days            
following exercise. 
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APPENDICES 
Appendix A: Informed Consent, Medical Questionnaire, ASU Lifestyle Questionnaire, ACSM 
Health Status Questionnaire 
 
Informed Consent 
 
TITLE: THE EFFECTS OF DEER ANTLER VELVET ON INDICES OF MUSCULAR 
STRENGTH, AEROBIC CAPACITY, ANAEROBIC POWER, AND BODY 
COMPOSITION 
 
PRINCIPAL INVESTIGATOR: 
Craig E. Broeder, Ph.D., Professor- The Dept. of Phys. Ed., Exercise, and Sport Sciences 
 
You have been invited to participate in a research experiment entitled: The Effects of Deer 
Antler Velvet on Indices of Muscular Strength, Aerobic Capacity, Anaerobic Power 
and Body Composition. The purpose of this study is to determine the physiological and 
psychological effects of 10-weeks of 3,000 mg/day (2-pills/day) supplementation (1-pill prior 
to and 1-pill immediately following a person’s workout) using a supplement known as Deer 
Antler Velvet for male subjects between the ages of 20 and 35 with at least 4 years of weight 
lifting experience. Deer antler velvet is a nutritional supplement, which may help my body 
improve muscular strength and physical work performance.  
The nature of this study is as follows. Forty male volunteers between the ages of 20 and 35 
years, currently training and with a minimum of 4 years of weight lifting experience will be 
participating in this study. You have been invited to participate in this study because you are 
interested in resistance training and improving exercise performance. 
 
Physiological Testing 
As a participant in this study, you will complete the following procedures: 
Figure 1. A comprehensive pre- and posttreatment physical fitness exams including the 
measurements of: 
• height, weight, and body composition measured by dual-photon absorption and 
total body water by bioelectrical impedance 
• a determination of my aerobic and anaerobic capacity with a resting/exercising 
electrocardiogram (EKG) 
• a determination of my total body strength using a ramp protocol (weight 
resistance is gradually increased until my maximal lifting capacity is determined) 
for achieving a 1-repetition upper strength limit on the bench press and leg press  
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• a comprehensive blood profile including total cholesterol with subtractions (HDL-
good cholesterol, LDL-bad cholesterol, triglycerides-form of fat stored in blood), 
apolipoproteins which counts the number of HDL and LDL molecules, liver 
enzymes, and a blood count. 
• a psychological assessment for mood and sexual function 
 
Figure 1. A ten week intervention period consuming either a 2 pills/day placebo or deer 
antler velvet supplement (See Figure 1) 
 
40 Male Volunteers With 
Greater Than 4-Years Weight Lifting Experience 
(Age 20 to 35) 
 
Posttreatment-testing Protocol Performed At 
Weeks 5 and 10
Ten Weeks of Free Living, Unchanging Diet 
Randomly assigned (as in flipping a coin)  
to a placebo group or  
 deer antler velvet group  
 
(Deer Antler Velvet = 20 Subjects) 
(Placebo = 20 Subjects) 
 
(Placebo or Supplement Ingested 60 minutes prior to training 
And 60 minutes following training.) 
(Taken as instructed on non-training days)
Pre-testing Protocol Performed 
 
40 Males Currently Training 
 
Figure 1. Flow Chart for Program Acceptance and Treatment Assignment 
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 Explanation of Procedures 
Your bone density will be measured by dual-photon absorption (a x-ray type device) as well 
as your total body water will be measured by determining how well a small electrical current 
is transmitted through my body (Bioelectrical Impedance). Together, the results of your body 
weight on land, bone density measure, and total body water will be used to determine the 
amount of bone, muscle, soft-tissue, and fat on your body before and after the study’s 
treatment period. 
 
A graded treadmill test will be used to determine your aerobic capacity before and after the 
10 week study period. This test will begin with a three-minute warm-up period with the 
speed and grade set at 1.7 mph and 0%, respectively. After the warm-up period, either speed 
or percent grade will be increased gradually until you can no longer continue. During this test 
procedure, your heart rate will be monitored using a heart monitor device (EKG) and the 
amount of oxygen you consume will be measured using a computer based measurement 
system.  
 
You will also be tested for your anaerobic capacity by running on a treadmill or pedaling a 
cycle at a workload greater than your maximal aerobic capacity test until fatigue before and 
after the 10 week study period.  
 
Your total body strength will be measured using a gradually increasing resistance protocol 
for determining the amount of weight you can lift on the bench press (a measure of upper 
body strength) and leg press (a measure of leg strength) one time (1-RM). You will also be 
asked to perform both of these tests at 70% of the measured maximum weight to determine 
how many repetitions are possible. These strength-testing procedures will be performed prior 
to, at week 5, and following the 10 week study period. 
 
You will be required to have 6-8 tablespoons of blood drawn so that a comprehensive blood 
profile can be performed prior to and following the 10-week study period. Your blood will be 
analyzed to determine how your blood lipids, liver, and kidney function were effected by 
taking the deer antler velvet supplement. In addition, another 2-3 tablespoons of blood will 
be drawn at the same time to determine my oxygen carrying capacity and red blood cell 
levels. Finally, blood samples will be taken (2-3 tablespoons each sample) before and after a 
normal 60 to 90 minute weight lifting session to assess if deer antler velvet supplementation 
can prevent muscle soreness markers at weeks 0, 5, and 10. 
 
 59
You will also complete a questionnaire prior to and after the 10-week study period that will 
be used to evaluate your mood and perception, sexual function and overall feeling of 
wellness or well being. You understand that the information taken in this questionnaire will 
only be used to determine what perceived effects the treatment had on your mood and sexual 
function. 
 
In order to account for any change in dietary intakes you will complete a three-day dietary 
diary prior to, at the end of week 5 and following the 10-week study period. 
 
You realize that after completing all pretreatment requirements outlined above you will 
continue to participate in your own training program that will be monitored and established 
for maximum strength gains, all the while maintaining your current dietary habits. 
 
You will not be allowed to take any performance enhancing supplements during this trial 
period such as creatine, HMB, androstenedione/diol, 19-norandrostenedione/diol or anabolic 
steroids. You further understand that you will have not taken the aforementioned for 
substances at least 8-weeks (2 months) prior to the beginning of this trial. 
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The initial comprehensive and post study physical exam will be associated with the 
following potential risks:  
 
♦ This is the first well-controlled clinical trial outside of the Government of New Zealand. 
The effects of this substance are scientifically unknown.  
♦ The risks associated with taking your blood include a slight possibility of discomfort, 
bruising, fainting, and in very rare cases a chance of infection at the area in which blood is 
drawn. 
♦ For bioelectrical impedance there are no obvious risks associated. However because of 
unfamiliarity with these procedures, you may experience anxiety before and during the 
procedures. 
♦ For the measurement of bone density (dual-photon absorption), you will be exposed to a 
small amount of radiation that is equal to watching three hours of television which equals 
0.02 rem of x-ray exposure. 
♦ During the measurement of my aerobic, anaerobic capacity and cardiac function testing, 
you may experience discomfort at the higher levels of exercise, shortness of breath, 
muscular fatigue, muscle strain, and a rapid heart rate. There is also a risk of death from 
heart attack during this type of high intensity exercise testing. To minimize this risk, the 
Guidelines for American College of Sports Medicine will be followed. 
♦ During the strength testing procedures, there is a very slight risk of muscle strain. 
♦ There are no obvious risks associated with the psychological mood and sexual function 
assessment and dietary recall assessments. However because of unfamiliarity with these 
procedures, you may experience anxiety before and during the procedures and some 
questions asked on the surveys may be offensive to some individuals. 
 
 
The benefits for participating in this study include two comprehensive medical exams 
completely free of charge ranging in value between $1,500 to $2,000.  
Participation in this research experiment is voluntary. You may refuse to participate. You can 
quit at any time. You may quit by contacting Craig E. Broeder, Ph.D. whose phone number is 
(423) 439-5380 or (423) 439-4265. You will be told immediately if any of the results of the 
study should reasonably be expected to make me change my mind about staying in the study. 
Your doctor may take me out of the study, if s/he decides it is not in my best interest to 
continue (i.e., not following study related directions, adverse event). You may be taken off 
the study if it ends early. 
You realize if you have any questions, problems or research-related medical problems at any 
time, you may call Craig E. Broeder, Ph.D. at (423) 429-5380 or (423) 926-9173; or Mary 
Kathryn Deaton at (423) 439-4265. You may call the chairman of the Institutional Review 
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Board at (423) 439-6134 for any questions you may have about your rights as a research 
subject. 
East Tennessee State University (ETSU) will pay the cost of emergency first aid for any 
injury, which may happen as a result of my being in this study. They will not pay for any 
other medical treatment. Claims against ETSU or any of its agents or employees may be 
submitted to the Tennessee Claims commission. These claims will be settled to the extent 
allowable as provided under TCA Section 9-8-307. For information about claims call the 
chairman of the Institutional Review Board of ETSU at (423) 439-6134. 
Every attempt will be made to see that my study results are kept confidential. A copy of the 
records from this study will be stored in The Human Performance Lab (E-113-Memorial 
Center) for at least 10 years after the end of this research. The results of this study may be 
published and/or presented at meetings without naming me as a subject. The ETSU IRB, 
FDA, Department of Health and Human Services and the principle investigators on this study 
have access to the study records. My medical records will be kept completely confidential 
according to current legal requirements. They will not be revealed unless required by law, or 
as noted above. 
By signing below, I certify that I have read or had this document read to me. I will be given a 
signed copy. I have been given the chance to ask questions and to discuss my participation 
with the investigators. I freely and voluntarily choose to be in this research project. 
 
 
 
             
SIGNATURE OF PATIENT      DATE 
 
             
SIGNATURE OF INVESTIGATOR     DATE 
 
             
SIGNATURE OF WITNESS      DATE 
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Dr. Craig Broeder would like to keep some blood samples that are not needed for your care. 
If you agree, it may be used in future research to learn more about how “deer antler velvet” 
supplementation affected your hormonal and general blood profiles.  
If you agree, your samples will be stored in a special specimen bank to hold until they are 
needed for research. Information about your participation will be stored only at The Human 
Performance Lab. This information will not be put in your medical records. You will get no 
direct benefit if you allow your specimens to be stored and used for research. But it might 
help you in some indirect way later on or help other people with medical problems or use 
deer antler supplementation. 
The choice to let Dr. Craig Broeder keep you blood for doing research is up to you. No 
matter what you decide to do, it will not affect your care. You may decide that we may keep 
your samples for research but later change your mind. If that happens, just tell your doctor 
and the specimen bank will then destroy any samples that they still have. Otherwise, the 
samples may be kept until they are used up, or until Dr. Broeder decides to destroy them. 
Your specimens will be used only for research and will not be sold. Some new products 
might be made because of the results of the research that uses your samples. These products 
might be sold sometime in the future, but you will not get paid. There will be no cost to you 
for any samples collected and stored in the specimen storage bank. 
Your blood will be stored for further analysis and possible further research. The sample(s) 
blood, tissue or fluids that you are giving might be used in studies that lead to new products 
for research, diagnosis and treatment. These products may have some commercial value. By 
signing this consent section, you authorize the use of your bodily fluids, substances or tissues 
for research purposes. You give up all rights to any commercial application related to 
information or samples that you have given during your participation in this research project. 
Please answer the following questions and check the answer that is right for you. 
I have been told that my samples will be coded and my identity will not 
be disclosed to anyone without my permission, except as required by law. 
 Yes  No 
I agree that remaining blood may be kept for use in future research to 
learn about, prevent, treat or cure medical problems or cancer. 
 Yes  No 
I agree that my doctor (or someone s/he chooses) may contact me in the 
future to ask me to take part in more research. 
 Yes  No 
 
              
Subject        DATE 
 
             
Witness        DATE 
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Medical Questionnaire 
 
Please list any current medical complaints: 
 
 
List any prescription or non-prescription medications that you take: 
 
Do you smoke at the present time? 
 If YES, How many packs a day? How many years? 
 
Did you Smoke in the past? 
 If YES, Quit Date? Packs/day? How many years? 
 
Has anyone in your family had heart disease, high blood pressure, or high cholesterol before age 
60? 
 
Have you ever had a treadmill stress test? (place an ‘x’ in the column to the left of one item) 
 
1) Never had a stress test. 
2) Yes- Result was Normal 
3) Yes-Result was Abnormal 
4) Yes- Don’t Know the Result 
 
Do you have excessive mental stress or insomnia? 
 
Do you have diabetes? 
 
Do you exercise regularly (at least 20-30 min. 3 days/week)? 
 
CARDIO-RESPIRATORY HISTORY 
 
Have you ever had any of the following? (place an “X” in the column to the left of any that 
apply) 
1. Heart Attack 
2. Stroke 
3. Any other heart disease 
4. Rheumatic Fever 
5. Emphysema, Bronchitis, or Asthma 
6. Poor circulation 
7. Elevated cholesterol levels 
8. Chest pain or tightness 
9. Skipped heart beats 
10. Irregular heart rhythm 
11. Shortness of breath 
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12. Dizziness 
13. High blood pressure 
14. High or low blood sugar 
 
List the following values if you know them: 
 
1. Total Cholesterol 
2. HDL: 
3. LDL: 
4. Blood Pressure: 
 
 
MUSCULOSKELETAL HISTORY 
 
Have you ever experienced swollen stiff, or painful joints? 
 
If yes-where? (place an X to the left of all that apply) 
 
1. Wrist 
2. Hip 
3. Shoulder 
4. Ankle 
5. Back 
6. Elbow 
7. Knee 
8. Neck 
9. Other 
 
Please give a brief description 
 
Please list any other muscular or bone illness or injury: 
 
Are you aware of any personal limitations (medical or other) not covered by this questionnaire 
which would restrict you participation in a planned program of diet and/or vigorous physical 
activity? 
 
If YES, please describe the nature of the limitation(s): 
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ASU Lifestyle Questionnaire 
 
A long, high-quality life is not a gift but rather the reward of wise lifestyle choices.  This self-test 
will help you understand just how closely you adhere to a wide variety of recommended health 
practices. Please answer to the best of you ability. 
Cigarette Smoking 
[ ] Never smoked or quit more than 15 years ago 
[ ] Ex-smoker, quit 5 to 15 years ago 
[ ] Ex-smoker quit within 5 years 
[ ] Current smoker, fewer than 20 cigarettes per day 
[ ] Current smoker, 20-40 cigarettes per day 
[ ] Current smoker, more than 40 cigarettes per day 
 
How many alcoholic drinks do you consume? 
 
[ ] Never use alcohol 
[ ] Less than once per week 
[ ] One to six times per week 
[ ] Once per day 
[ ] Two to three per day 
[ ] More than three per day 
 
How many cups (6 fluid oz. – do not include decaf) of coffee do you drink? 
 
[ ] Never use coffee 
[ ] Less than once per week 
[ ] One to six cups per week 
[ ] Once per day 
[ ] Two to four cups per day 
[ ] More than four per day 
 
How many glasses (8 fluid oz.) of water do you drink per day? 
 
[ ] More than six glasses per day 
[ ] Four to six glasses per day 
[ ] Fewer than four glasses per day 
 
For the following, carefully note the portion sizes as you answer the questions. Also, remember 
to include amounts used in cooking. Fruits and vegetables (1/2 to 1 cup): 
 
[ ] 5 or more servings each day 
[ ] 2-4 servings each day 
[ ] 1 or fewer servings each day 
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Grain products (breads, cereals, pasta, rice), one slice/one half cup: 
 
[ ] Six or more servings each day 
[ ] Three to five servings each day 
[ ] Two or fewer servings each day 
 
Red Meats (beef, pork, lamb, veal; not fish or poultry), 3 oz serving size. 
[ ] Seldom or never use 
[ ] Less than once per week 
[ ] One to four per week 
[ ] Five to six per week 
[ ] Daily 
 
Cheeses (do not include cottage or low-fat cheese), one ounce 
 
[ ] Seldom or never use 
[ ] Less than once per day 
[ ] More than once per day 
 
Whole mild (not skim or 1%) one cup: 
 
[ ] Seldom or never use 
[ ] Less than once per day 
[ ] More than once per day  
 
Eggs( including yolk), one whole: 
 
[ ] Seldom or never use 
[ ] One to two per week 
[ ] Three to four per week 
[ ] More than four per week 
 
Outside of your normal work or daily responsibilities, how often do you engage in exercise that 
makes you sweat for 20 continuous minutes: 
 
[ ] 5 or more times per week 
[ ] 4-3 times per week 
[ ] 1-2 times per week 
[ ]  Less than once per week 
[ ] Seldom or never 
 
How would you rate your body weight? 
 
[ ] Very close to ideal 
[ ] About 10% to high 
[ ] About 11-25% to high 
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[ ] About 26-40% too high 
[ ] More than 40% too high 
 
Mental/social/spiritual well-being. In general, how satisfied are you with your life? 
 
[ ] Mostly satisfied 
[ ] Partly satisfied 
[ ] Mostly disappointed 
 
How often do you get insufficient rest so that you are unable to function efficiently? 
 
[ ] Less than weekly 
[ ] Usually one night per week 
[ ] Two or three nights per week 
[ ] Four or more nights per week 
 
How would you describe the emotional stress you experience at you job (which includes being a 
student)? 
 
[ ] Experience average or low levels of stress 
[ ] Much stress but am able to cope with it 
[ ] Much stress and often feel unable to cope 
 
Have you suffered a serious personal loss or misfortune in the past year? (Divorce/separation, 
jail term death of a close person, job loss, disability). 
 
[ ] No 
[ ] Yes, one serious loss 
[ ] Yes, two or more serious losses 
 
How many friends and relatives (including your spouse) do you feel close to? (People that you 
feel at ease with, can talk to about private matters, and can call on for help). 
 
[ ] 10 or more 
[ ] 5 to 9 
[ ] 1 to 4 
[ ]  none 
 
How would you describe your spiritual health? (Ability to develop one’s spiritual nature to its 
fullest potential. This includes our ability to discover, articulate, and act on our own purpose in 
life? 
 
[ ] Good to excellent 
[ ] Fair to poor 
[ ] Very poor 
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Among your close relatives (parents, grandparents, aunts, uncles) how many deaths from heart 
disease or cancer have occurred before age 60? 
 
[ ]  None 
[ ]  One  
[ ]  Two or more 
 
What percentage of the time do you use seatbelts while driving or riding? 
 
[ ] 100% 
[ ] 50-99% 
[ ] 25-49% 
[ ] Less than 25% of the time 
 
How often do you see your physician for a physical checkup? 
 
[ ] At least once per year 
[ ] Only once every three years 
[ ] Only once every five years 
 
Your blood pressure is (if you do not know this value we highly suggest you have it taken. To 
estimate, select ‘Low or Normal’ if your weight and salt intake are low. Otherwise, select 
‘Moderately High’) 
 
[ ] Low or normal (less than 120/80) 
[ ] Borderline high (120/80 –139/89) 
[ ] Moderately high (140/90 – 159/94) 
[ ] Very high (160/95 and higher) 
 
Your serum cholesterol is  
 
[ ] low (less than 180 mg/dl) 
[ ] borderline high (180-199 md/dl) 
[ ] moderately high (200-239 mg/dl) 
[ ] very high (240 mg/dl and higher) 
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ACSM Health Status Questionnaire 
 
On this questionnaire, a number of questions regarding your physical health are to be answered. 
Please answer every question as accurately as possible so that a correct assessment can be made. 
Please place a check mark in the space to the left of the question to answer “YES”. Lieave blank 
if you answer is “No”. Please ask if you have any wuations. Your responses will be treated ina 
confidential manner. 
 
Today’s Date: ___/___/___ Your Name __________________________ 
 
__ Do you have any personal history of coronary or atherosclerotic disease? 
 
__Any personal history of metabolic disease (thyroid, renal, liver)? 
 
__ Have you had diabetes for less than 15 years? 
 
__ Have you experienced pain or discomfort in your chest apparently due to blood flow        
     deficiency? 
 
__Any unaccustomed shortness of breath? 
 
__Have you had any problems with dizziness of fainting? 
 
__ Do you have difficulty breathing while standing or sudden breathing problems at night? 
 
__ Do you suffer from ankle edema? 
 
__ Have you experienced rapid throbbing or fluttering of the heart? 
 
__ Have you experienced severe pain in leg muscles during walking? 
 
__ Do you have a known heart murmur? 
 
__ Do you have any family history of cardiac or pulmonary disease prior to age 55? 
 
__ Have you been assessed as hypertensive on at least 2 occasions? 
 
__ Has your serum cholesterol been measured at greater than 240 mg/dl? 
 
__ Are you a cigarette smoker? 
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Appendix B: Perceived Soreness Scale 
 
Date of Last Training Session ________________ 
 
The following is a questionnaire designed to evaluate that amount of muscle soreness (not joints) 
you are experiencing as a result of your strength training program. Please carefully consider each 
question before recording the number that best indicates how these muscles feel. 
 
Key: 0  1 2 3 4 5 6 7 8 9 10 
       None      Very Mild          Mild        Moderate       Very Sore    Excruciating  
 
Neck   _____   Buttocks   _____     
 
Shoulders  _____   Hips     _____ 
 
Upper Back  _____   Groin   _____ 
 
Triceps  _____   Hamstring  _____ 
 
Biceps   _____   Quadriceps  _____ 
 
Chest   _____   Calf Muscle  _____ 
 
Abdomen  _____   Shins   _____ 
 
Forearms  _____   Other   _____ 
 
Lower Back  _____ 
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Appendix C: Eccentric Trial 
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Squat Exercises 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medicine Ball Jumps 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box Jumps 
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